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Abstract  I 
1 Abstract 
Intracellular communication at the molecular level is mainly dependent on 
posttranslational modifications and interplay between those. ADP-ribosylation, the 
transfer of ADP-ribose from NAD+ to substrates and especially its polymerization, is 
involved in processes like signal transduction, gene transcription and DNA damage 
repair. The latter is mainly mediated by ARTD1/PARP1, the founding member of the 
group of ADP-ribosyltransferases (ARTs). Its functions through poly-ADP-ribosylation 
have been studied well. Mono-ADP-ribosyltransferase activity however was 
previously only reported for bacterial toxins and extracellular ARTs. Yet although 
evidence for intracellular ADP-ribosylation is still missing, ARTD10 was recently 
shown to possess mono-ADP-ribosylation activity in vitro.  
First attempts to obtain insight into its physiological relevance revealed that the 
enzyme is implicated in transformation and proliferation. In this work we expanded on 
these findings and generated stable HeLa cell lines, which inducibly express 
ARTD10 or different constructs thereof. The expression of the wild-type protein 
confirmed prior observations, as it inhibited proliferation. By follow-up experiments 
this effect could be linked to the induction of apoptosis in those cells. This was 
dependent on catalytic activity, as ARTD10-G888W, a catalytic inactive mutant, was 
not cytotoxic. In addition, we could observe cleavage of ARTD10 during apoptosis, 
an observation also made for ARTD1. Processing at ‘I A M D406 S’ resulted in a 
catalytically active fragment, which was no longer able to stimulate apoptosis. 
Moreover, the inflammatory caspase-1 also processed ARTD10 in vitro at 
“W T P D581 S” potentially linking ARTD10 cleavage to a second cellular pathway 
involving caspases.  
In both cases the RNA recognition motif as well as a glycine-rich region were 
separated from the catalytic center. The loss of pro-apoptotic activity alongside the 
separation of these domains hints towards an important function of ARTD10 in an 
RRM-linked process, like RNA processing or transport, or a regulation of ARTD10 
itself through the RRM. Further studies are necessary to unravel the possible 
implications of ARTD10 in those pathways and could provide further insight into the 
physiological role of ARTD10 based on the findings made in this work. 
Zusammenfassung  II 
2 Zusammenfassung 
Die intrazelluläre Kommunikation auf molekularer Ebene ist hauptsächlich abhängig 
von posttranslationalen Modifikationen und ihrem Zusammenspiel. 
ADP-Ribosylierung, die Übertragung von ADP-Ribose von NAD+ auf Substrate und 
die Generierung von ADP-Ribose-Polymeren ist an Prozessen wie 
Signaltransduktion, Gentranskription und DNS-Reparatur beteiligt. Letzteres wird vor 
allem durch ARTD1/PARP1 vermittelt, dem Gründungsmitglied der Gruppe von ADP-
Ribosyltransferasen (ARTs). Die durch seine poly-ADP-Ribosylierung-Aktivität 
vermittelten Funktionen wurden gut untersucht. Mono-ADP-Ribosetransferase-
Aktivität wurde jedoch bisher nur für bakterielle Toxine und extrazelluläre ARTs 
nachgewiesen. Obwohl Beweise für die intrazelluläre ADP-Ribosylierung noch fehlen, 
wurde kürzlich in vitro gezeigt, dass ARTD10 mono-ADP-Ribosetransferase-Aktivität 
besitzt. 
Erste Versuche Einblicke in die physiologische Relevanz zu erhalten zeigten, dass 
das Enzym an Transformation und Proliferation beteiligt ist. Auf diesen 
Erkenntnissen aufbauend wurden stabile HeLa-Zelllinien generiert, die induzierbar 
ARTD10 oder verschiedene Konstrukte desselben herstellen. Die Expression des 
Wildtyp-Proteins bestätigte die früheren Beobachtungen, nach denen ARTD10 die 
Proliferation inhibiert. In nachfolgenden Experimenten konnte dieser Effekt auf die 
Induktion von Apoptose in den Zellen zurückgeführt werden. Dies war abhängig von 
katalytischer Aktivität, da ARTD10-G888W, eine inaktive Mutante, nicht zytotoxisch 
war. Zusätzlich konnte die Spaltung von ARTD10 während der Apoptose beobachtet 
werden, ein Effekt der auch für ARTD1 bekannt ist. Spaltung im Motiv "I A M D406 S" 
führte zu einem katalytisch aktiven Fragment, welches jedoch nicht mehr in der Lage 
war Apoptose zu stimulieren. Analog dazu spaltete auch die inflammatorische 
Caspase-1 ARTD10 in vitro im Motiv "W T P D581 S", ein Ergebnis welches die 
Spaltung von ARTD10 mit einem zweiten zellulären Caspase-regulierten Signalweg 
verbindet. 
In beiden Fällen wird das RNA Erkennungsmotiv sowie eine Glycin-reiche Region 
vom katalytischen Zentrum getrennt. Der Verlust der pro-apoptotischen Aktivität 
durch Trennung dieser Bereiche könnte einerseits auf eine wichtige Funktion von 
ARTD10 in einem RRM-abhängigen Prozess, wie RNA-Prozessierung oder 
Transport, hindeuten oder andererseits eine Regulation von ARTD10 durch das RRM 
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bedeuten. Auf den Ergebnissen dieser Arbeit beruhende weitere Studien sind 
notwendig, um mögliche Einflüsse von ARTD10 in diese Wege zu untersuchen und 
tiefere Einblicke in die physiologische Rolle von ARTD10 zu ermöglichen. 
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4 Introduction 
4.1 ADP-ribosylation and relevant enzymes 
4.1.1 Introduction 
ADP-ribosylation is a process, were ADP-Ribose (ADPr) is transferred from NAD to a 
substrate or to itself in an elongation reaction mechanism. The cofactor NAD is 
thereby hydrolyzed and the vitamin nicotinamide is released [Figure 1]. As the targets 
of ADP-ribosylation are proteins, it is classified as post-translational modification 
(PTM). Similar to ubiquitination or the well studied phosphorylation, ADP-ribosylation 
is involved in many cellular processes, like DNA repair, stress response, 
inflammation, cell division, regulation of transcription and RNA interference, with 
even more functions getting discovered each day (Hassa and Hottiger, 2002; Kraus, 
2008; Luo and Kraus, 2012). With new information about motifs, recognition domains, 
new substrates and ADPr hydrolases a large cellular network of ADP-ribosylation is 
forming which is, although less abundant, most likely as important and complex as 
some other previously studied PTMs.  
 
 
Figure 1. Schematic representation of the mono-ADP-ribosylation reaction. 
The chemical structure of the mono-ADP-ribosylation reaction to an acceptor protein is shown.  Mono-ADP-
ribosyltransferases (mART) catalyze the addition of ADP-ribose to a substrate using nicotinamide adenine 
dinucleotide (NAD+) as cofactor, with the nicotinamide part of the molecule being released. ADP-
ribosylhydrolases (ARH) remove the ADP-ribose moiety from a substrate. 
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ADP-ribosylation was recognized as a protein modification 50 years ago. Starting 
with the discovery of ADPr polymers in eukaryotic cells in 1963, the structure was 
solved soon after and mono-ADP-ribosylation was uncovered to be the enzymatic 
activity of certain bacterial toxins (Chambon et al., 1963; Gill et al., 1969; Honjo et al., 
1968; Reeder et al., 1967). Over the next decades progress was made mainly in the 
field of poly-ADP-ribosylation. The first eukaryotic enzyme PARP was discovered, 
which was responsible for chromatin ADP-ribosylation upon DNA damage (Alkhatib 
et al., 1987; Kurosaki et al., 1987).  
Mono-ADP-ribosylation in eukaryotic cells remained elusive until the end of the last 
century, when the so-called ecto-mARTs, mARTs located on the extracellular side of 
the plasma membrane, were found (Okazaki et al., 1996; Zolkiewska et al., 1992). 
Only recently their intracellular counterparts were identified and are now in focus of 
current investigations. 
 
4.1.2 Structural features and nomenclature 
ADP-ribosylation is a process, which not only exists in mammalians. As mentioned 
earlier several bacterial toxins are classified as ADP-ribosyltransferases and a 
considerable number of genes encoding ADP-ribosyltransferases are found in a 
variety of species ranging from bacteria and fungi to plants and animals (Hottiger et 
al., 2010). 
 
Despite the very different nature of these proteins, they share a common structure of 
their catalytic core and NAD binding region. The identification of those structures 
became easier with more and more catalytic domains of ARTs being crystallized with 
their cofactor or analogues thereof (Bell and Eisenberg, 1996). The fundamental 
motif of the catalytic domain is a 6-stranded ß-sheet structure, which accounts for 
NAD-binding as well as catalytic activity. Three main motifs are responsible for these 
functions and are completely or partially conserved throughout all three kingdoms of 
life. One amino acid of each motif contributes to the formation of a catalytic triad by 
which ARTs can be classified. Cholera toxin-like bacterial ARTs as well as ecto-
mARTs show an R-S-E motif, which is replaced by an H-Y-E motif or slight variants 
thereof in diphtheria toxin-like bacterial ARTs and intracellular eukaryotic ARTs.  
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Initially when only one intracellular mammalian enzyme was known, the reaction 
product gave the enzyme its name, poly-ADP-ribose polymerase (PARP). Additional 
enzymes were identified by in silico screening and numbered in ascending order 
(Ame et al., 2004; Otto et al., 2005). But with the growing knowledge that several of 
these enzymes only catalyze the addition of one ADP-ribose unit or are even inactive, 
a new nomenclature was proposed combining features of the catalytic activity and 
core structure in regard to the bacterial toxins (Hottiger et al., 2010).  
 
The ecto-mARTs containing the catalytic R-S-E motif belong to the group of cholera 
toxin-like ARTs, now referred to as ARTCs. The second group comprises only of the 
NAD+-dependent tRNA 2’-phosphotransferase TpT, for which until now ADP-
ribosylation activity is only postulated. The third and largest group covers the 
enzymes originally named PARPs. Due to the triad similarity to the bacterial toxin 
triad H-Y-E, they were named diphtheria toxin-like ARTs, abbreviated ARTDs. Their 
17 members can be further subdivided into 2 groups according to the third amino 
acid in this triad, which was shown to be responsible for poly-ART activity 
(Marsischky et al., 1995; Rolli et al., 1997). Only in the 6 PARP1-like ARTs this 
glutamate is present and in addition those show also a characteristic extended loop 
between the β4 and β5 sheet, which is also found in bacterial ARTs and is thought to 
participate in the recognition of substrates (Sun et al., 2004). The remaining 11 
enzymes, which lack the catalytic E, are currently investigated as mono-ARTs or 
inactive enzymes. Using a reaction mechanism called “substrate assisted catalysis” 
ARTD10 was the first of the ARTD family members for which mART activity was 
confirmed (Kleine et al., 2008).  
 
Apart from their conserved catalytic domain the ARTDs present a great variety of 
structural and functional domains, like RRM, WWE, Macro, NES or ZF, which are 
potentially responsible for protein-protein interaction, interaction with DNA/RNA, 
subcellular localization and more.  A list of the known human ARTDs and their 
characteristic features is shown in Table 1. 
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Table 1. The mammalian ARTD family. [adapted from (Gibson and Kraus, 2012)] 
Names  
Size 
(aa)‡ 
Subcellular 
localization 
Triad 
motif 
Enzym. 
activity 
Key functional 
motifs 
and domains|| PARP Alternative Transferase* Subclass 
PARP1  ARTD1 
DNA-
dependent 1,014 Nuclear H-Y-E P/B 
WGR, zinc-
fingers and 
BRCT 
PARP2  ARTD2 
DNA-
dependent 570 Nuclear H-Y-E P/B WGR 
PARP3  ARTD3 
DNA-
dependent 540 Nuclear H-Y-E M WGR 
PARP4 vPARP ARTD4  1,724 
Cytosolic 
(vault 
particle) 
H-Y-E P BRCT 
PARP5A Tankyrase 1 ARTD5 Tankyrase 1,327 Nuclear and cytosolic H-Y-E P/O Ankyrin repeat 
PARP5B Tankyrase 2 and PARP6¶ ARTD6 Tankyrase 1,166 
Nuclear and 
cytosolic H-Y-E P/O Ankyrin repeat 
PARP6¶  ARTD17  322 ND H-Y-Y M  
PARP7 TIPARP and RM1 ARTD14 
CCCH 
PARP 657 ND H-Y-I M 
Zinc-fingers and 
WWE 
PARP8  ARTD16  854 ND H-Y-I M  
PARP9 BAL1 ARTD9 macroPARP 854 ND Q-Y-T M Macrodomain 
PARP10  ARTD10  1,025 
Nuclear and 
cytosolic H-Y-I M  
PARP11  ARTD11  331 ND H-Y-I M WWE 
PARP12 ZC3HDC1 ARTD12 CCCH PARP 701 
Cytosolic 
(stress 
granules) 
H-Y-I M Zinc-fingers and WWE 
PARP13 ZC3HAV1 and ZAP1 ARTD13 
CCCH 
PARP 902 
Cytosolic 
(stress 
granules) 
H-Y-V M Zinc-fingers and WWE 
PARP14 BAL2 and COAST6 ARTD8 macroPARP 1,801 
Cytosolic 
(stress 
granules) 
H-Y-L M Macrodomain and WWE 
PARP15 BAL3 ARTD7 macroPARP 444 
Cytosolic 
(stress 
granules) 
H-Y-L M Macrodomain 
PARP16  ARTD15  630 ND H-Y-I M  
aa, amino acid; ARTD, ADP-ribosyltransferase; BAL, B-aggressive lymphoma protein; COAST6, collaborator of 
signal transducer and activator of transcription 6; ND, not determined; PARP, poly(ADP-ribose) polymerase; 
vPARP, vault PARP; ZAP1, zinc-finger antiviral protein 1; ZC3HAV1, zinc-finger CCCH-type antiviral protein 1; 
ZC3HDC1, zinc-finger CCCH domain-containing protein 1. *Based on the recently suggested revised 
nomenclature (Hottiger et al., 2010). ‡Number of amino acids of the human protein. §Known or predicted 
enzymatic activity: mono- (M), oligo- (O) or poly(ADP-ribosyl)ation (P), or branching (B). ||All PARP family 
members contain a PARP domain. ¶PARP6, which refers to two different proteins, is an example of the 
degeneracy of the PARP nomenclature in the existing literature. 
 
4.1.3 PARP1/ARTD1 
ARTD1/PARP1 is the founding member of the human intracellular ARTD family. 
Being responsible for approximately 85% of the cells poly-ADP-ribosylation activity it 
is also the most prominent enzyme (Shieh et al., 1998). It is a nuclear protein of 
116 kD that is characterized mainly by 3 domains [Figure 2]. The N-terminal DNA-
binding domain contains 3 zinc fingers of which 1 and 2 are responsible for ssDNA 
break recognition (Ikejima et al., 1990). The recently identified third zinc finger, which 
is separated from the first two by a nuclear localization sequence (NLS), is important 
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for the activation of the enzyme (Langelier et al., 2008). In addition to its obvious 
function the automodification domain in the center of the protein mediates protein-
protein interactions with DNA repair enzymes through the BRCT (BRCA1 C-
terminus) fold. The third domain at the C-terminus contains the conserved 
ADP-ribosyltransferase domain with the catalytic H-Y-E motif and is therefore 
responsible for the catalytic function of the protein. 
 
 
Figure 2. ARTD1, the bona-fide poly-APDr transferase [adapted from (David et al., 2009)]. 
ARTD1, formerly PARP1, is the founding member of the ADPr-transferase superfamily. The schematic picture 
shows the domain organization of this multifunctional protein. At the N-terminus it contains two functional zinc-
fingers that cooperate in DNA binding, followed by an NLS, the domain responsible for the nuclear localization of 
ARTD1. The protein center is characterized by a BRCT fold that mediates protein-protein binding and in addition 
serves as target for extensive automodification. The catalytic domain common to all family members is the 
catalytic active part of the protein and is localized at the far C-terminus. NLS, nuclear localization signal; BRCT, 
BRCA1 C-terminus. 
 
ARTD1 is best known for its function in the base excision pathway during DNA 
damage repair. As mentioned above it senses single strand breaks through the 
N-terminal zinc fingers, which activates the enzyme. But also other DNA structures 
like hairpins, cruciform DNA and unusual loops are recognized (Lonskaya et al., 
2005). Binding of the zinc fingers leads to a conformational change in the protein and 
subsequently to its activation, followed by extensive automodification as well as 
modification of histones H1 and H2B (Langelier et al., 2012; Poirier et al., 1982). This 
occurs in combination with PARP2/ARTD2, which not only heterodimerizes with 
ARTD1 and shares different binding partners, but also seems to compensate for 
some ARTD1 functions, as ARTD1/2 knockouts are embryonically lethal compared to 
the single knockouts (Menissier de Murcia et al., 2003; Schreiber et al., 2002). The 
synthesized PAR chains have a length of up to 200 ADP-ribose units and can be 
branched every 20-50 units (Kiehlbauch et al., 1993). The elongation occurs through 
an α(1-2)-O-glycosidic bond between the nicotinamide proximal ribose and the 
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adenine proximal ribose of the growing poly-ADPr (PAR) chain. In a branching 
reaction the nicotinamide proximal ribose of the PAR chain is likewise used as an 
acceptor. The extensive ADP-ribosylation has two effects. On one hand it results in 
decondensation of chromatin as the PAR chains displace histones (Poirier et al., 
1982; Zahradka and Ebisuzaki, 1982). On the other hand the PAR chains function as 
binding platform for DNA repair enzymes, like XRCC1, which thereby accumulate at 
the site of DNA damage (Masson et al., 1998). The growing number of negative 
charges added to ARTD1 itself through automodification leads to an electrostatic 
repulsion from the DNA and subsequent loss of activity. This is followed by a 
degradation of the PAR chains through PAR hydrolyzing enzymes like PARG (poly-
ADP-ribose glycohydrolase) (D'Amours et al., 1999; Zahradka and Ebisuzaki, 1982). 
Apart from this well-known function in DNA repair, ARTD1 is also involved in 
inflammation and apoptosis, findings that were made using ARTD1 knockout mice or 
the in vivo application of inhibitors (Altmeyer et al., 2010; Liaudet et al., 2002).  In 
inflammatory diseases it is implicated in pathogen associated as well as in 
noninfectious inflammation, for example in the ischemia reperfusion model or allergy-
associated inflammation (Ba et al., 2010; Oumouna et al., 2006; Thiemermann et al., 
1997). Studies indicate that ARTD1 influences inflammation at different levels. 
Analogue to the function during base excision repair, extensive PAR chains can relax 
the chromatin and lead to a different gene expression pattern. Other groups reported, 
that ARTD1 regulates the inflammatory response by modifying key enzymes in 
signaling cascades involved in inflammation, like RELA/p65, a subunit of the NF-κB 
signaling pathway. PARylated p65 cannot bind to the nuclear export factor Crm1 and 
is thereby retained in the nucleus, leading to prolonged signal transduction (Zerfaoui 
et al., 2010). In addition inactive ARTD1 also binds directly to promoters, prevents 
NF-κB from binding and thereby inhibits transcription, like it is the case for the C-X-C-
motif chemokine ligand 1 gene. When stimulated, the PARylation of ARTD1 leads to 
its dissociation from the promoter and the subsequent activation of the gene (Amiri et 
al., 2006).  
A field of investigation, which is related to inflammation, is ARTD1’s implication in cell 
death. Active promotion of cell death takes place in situations with extensive amounts 
of DNA damage or oxidative stress. From the point of hyperactivation of ARTD1 the 
rapid degradation and resynthesis of PAR chains can lead to NAD and subsequently 
ATP depletion, which results in a necrotic cell death called parthanatos (Andrabi et 
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al., 2008). Another path leads the cell into regulated breakdown and apoptosis, which 
is nonetheless caspase independent (Yu et al., 2002). The key component of this 
mechanism is the apoptosis-inducing factor (AIF), an oxidoreductase, which resides 
in the mitochondrial intermembrane space (IMS) (Otera et al., 2005). Due to the 
strong activation of ARTD1 in combination with the also endoglycosidic activity of 
PARG, PAR chains are formed and translocate throughout the cell. At mitochondria 
those PAR chains lead to the conversion of membrane bound to free AIF and its 
subsequent release. However the exact mechanism by which the PAR chains 
function is not clear yet (Yu et al., 2006). When released AIF travels to the nucleus, 
where it stimulates chromatin condensation and further promotes cell death which 
shows hallmarks of apoptosis, like phosphatidylserine exposure and mitochondrial 
membrane depolarization, but is caspase independent (Susin et al., 1999).  
Apart from these active implications in cell death, ARTD1 is also targeted by 
caspases as well as granzymes during normal apoptotic events (Lazebnik et al., 
1994; Tewari et al., 1995; Zhu et al., 2009). ARTD1 is cleaved at D214 by caspase-3, 
an apoptotic executioner caspases, as well as by the inflammatory caspases 1 and 7 
(Malireddi et al., 2010; Zhu et al., 2009). The protein is thereby inactivated and 
fragments can even exhibit a dominant negative effect. The hypothesis is that in 
cases where the damage to the cell is to severe, the repair pathways are inactivated 
to spare remaining energy for the ordered breakdown. The analysis of ARTD1 
fragmentation is commonly used as evidence for apoptosis, i.e. the activation of 
caspases. 
 
4.1.4 Binding domains and antagonists 
ADP-ribose modifications, introduced in the preceding chapters, are involved in a 
variety of processes through regulation of intermolecular interaction, scaffolding and 
connection to other posttranslational mechanisms. The resulting influence on a cell 
has to be tightly controlled, to prevent errors, malfunction and overreaction; incidents 
that would otherwise lead to disturbed cell function or even cell death. Not long after 
the discovery of ARTD1, PARG was identified, an enzyme capable of hydrolyzing 
PAR chains (Miwa et al., 1974). It cleaves both at the end and inside the polymers, 
but with prevalence to endohydrolyzation resulting in the production of mono-ADP-
ribose as well as oligomers and is therefore important for the normal turnover and 
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metabolism of ADPr (Davidovic et al., 2001; Kim et al., 2005). On the other hand 
PARG is also involved in ARTD1 related cell death, as it facilitates the extensive 
NAD consumption of ARTD1 in parthanatos and produces ADP-ribose oligomers, 
which mediate AIF translocation to the nucleus (Andrabi et al., 2008; Yu et al., 2006).  
The pivotal role of PARG in cellular processes and ADP-ribosylation homeostasis is 
strengthened by findings obtained from knockout experiments. Mice depleted of 
PARG die at embryonic day 3.5 and murine embryo fibroblasts (MEFs) that lack 
PARG accumulate PAR and show a strongly increased sensitivity to DNA damage 
(Koh et al., 2004). With findings in the early 90s a second class of enzymes came 
into play. The ADP-ribose glycohydrolase ARH was found to reverse mono-ADP-
ribose modifications on arginine, an enzymatic activity that was not seen with PARG 
(Moss et al., 1992; Takada et al., 1993). In silico screening revealed two additional 
members of the ARH family (Glowacki et al., 2002). ARH2 does not possess catalytic 
activity, but ARH3 was shown to have PARG-like activity, hydrolyzing PAR but not 
mADPr (Oka et al., 2006). Except for indications that ARH3 is involved in PAR 
degradation at mitochondria, little is known of its in vivo functions (Niere et al., 2012). 
The same is true for the third class of proteins with ADP-ribosylhydrolase activity. 
The NUDIX class of enzymes contains 24 human genes and catalyzes the cleavage 
of the pyrophosphate in nucleoside-diphosphate-containing molecules, which 
includes PAR chains (McLennan, 2006). NUDIX proteins were early on defined as 
housecleaning enzymes as they play a role in the recycling of metabolites and 
reaction intermediates, but their role in opposing ADP-ribosylation has to be clarified 
(Bessman et al., 1996).  
 
Apart from the interplay between ARTs and hydrolases the process of recognizing 
and binding of ADPr has become a research focus in the last decade. Much like 
other posttranslational modifications of proteins, ADP-ribosylation also has its binding 
domains integrating it in recognition and signaling processes. The first domain to bind 
PAR was described in 2000, a 20 amino acid consensus sequence containing a 
basic-residue rich cluster and a hydrophobic part containing single basic amino acids 
(Pleschke et al., 2000). Several DNA damage checkpoint proteins were revealed that 
contained this PAR-binding motif (PBM). A more recent in silico screen broadened 
the range of proteins containing a PBM to proteins mostly involved in DNA damage 
repair, chromatin remodeling and RNA processing (Gagne et al., 2008). Among PBM 
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proteins are known PAR binders like XRCC1 and DNA ligase III as well as AIF, the 
factor involved in ARTD1 induced cell death (Wang et al., 2011). The PBM, as the 
name states, is rather a motif that can be interspersed in other domains then a 
structural domain itself. Therefore it is likely that it controls the functionality of those 
domains that contain such a motif due to the potential interaction with PAR (Kalisch 
et al., 2012). The first protein structure to bind ADPr, the so-called macrodomain, 
was initially recognized in the early 90s in the core histone macroH2A1.1, without 
knowing its function (Pehrson and Fried, 1992). Later on a study focusing on the 
protein Af1521 from Archaeoglobus fulgidus proved that its macrodomain as well as 
macrodomains from macroH2A1.1 and other proteins bind ADPr (Karras et al., 2005). 
The structure of specific macrodomains revealed that these domains bind ADPr in 
PAR chains. Thus macrodomains are interaction partners of poly-ADPr and possibly 
of mono-ADP-ribosylated substrates (Timinszky et al., 2009). In humans 11 proteins 
are predicted to contain a macrodomain, a 130-190 amino acid residue motif, either 
as single domain or up to a triple repeat (Kalisch et al., 2012). The implication in the 
recruitment of factors to sites of DNA damage is currently best understood. For 
example the former mentioned macroH2A1.1 as well as the helicase ALC1 bind to 
PAR upon ARTD1 activation and remodel the chromatin, resulting in facilitation of 
DNA repair (Ahel et al., 2009; Timinszky et al., 2009). Two additional PAR-binding 
domains are the PAR-binding zinc fingers (PBZ) and the WWE domain. PBZs were 
only found in 3 proteins were they are essential for the binding within PAR molecules. 
The interstrand crosslink repair protein SNM1 contains only one PBZ whereas the 
two DNA damage response proteins APLF and CHFR contain a cooperative tandem 
repeat, which was shown to increase binding affinity (Ahel et al., 2008; Li et al., 2010). 
The mitotic checkpoint protein CHFR is linking two posttranslational modifications, as 
it contains a RING domain and is able to ubiquitinate ARTD1 upon mitotic stress and 
also upon ARTD1 activation, leading to its degradation (Kashima et al., 2012).  
WWE domains were likewise recognized in molecules involved in ubiquitination and 
ADP-ribosylation by sequence profiling (Aravind, 2001). Three groups published 
independently that the WWE containing E3 ligase RNF146 binds to PAR (Andrabi et 
al., 2011; Kang et al., 2011; Zhang et al., 2011). Upon interaction with bound or free 
PAR RNF143 polyubiquitinates itself, automodified ARTD1, and other DNA repair 
factors, thereby targeting the substrates for proteasomal degradation (Kang et al., 
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2011). In contrast to the macro domain, the WWE domain recognizes the internal 
iso-ADPr rendering it specific for PAR (Wang et al., 2012). 
 
4.1.5 ARTD10/PARP10 
ARTD10, the former PARP10, is a mammalian mono-ART. The putative protein was 
found through in silico screening together with other members of the former 
mentioned seventeen PARP family members (Ame et al., 2004). Evidence for the 
actual mRNA/protein was found and the protein was further characterized. Its gene is 
located to chromosome 8q24.3 in a head-to-tail fashion with the plectin 1 gene 
(Lesniewicz et al., 2005; Yu et al., 2005). The gene consists of 11 exons and has a 
length of more than 9.3 kb. It is transcribed as a 3.4 kb mRNA which encodes for 
1025 amino acids of human ARTD10. Although the calculated molecular mass is 110 
kD, the protein has an apparent mass in SDS-PAGE of 150 kD. Until now no 
isoforms through alternative start codons or splice variants are described. 
As mentioned in the introductory chapter to the ART family ARTD10 is a confirmed 
mono-ART. The catalytic glutamate in the H-Y-E triad, which is required for 
elongation in ARTD1, is exchanged for an isoleucine thereby abolishing 
polymerization reactions (Kleine et al., 2008; Marsischky et al., 1995). The transfer of 
the single ADP-ribose unit is mediated through a reaction called substrate assisted 
catalysis, wherein the target glutamate of the receptor protein is replacing the absent 
glutamate in the active center of the protein. As the modified amino acid is afterwards 
not available for another round of catalysis, the reaction stops. Despite this 
straightforward mechanism, it is still discussed if glutamates are the target amino 
acids. 
The main research focus at the moment is directed towards the targets of ARTD10 to 
elucidate its cellular functions. Beside itself ARTD10 also modifies all four core 
histones, which are currently the only published substrates. ProtoArrays with more 
than 8000 proteins spotted are currently used to provide further inside into ARTD10 
targets (Feijs et al. submitted). The detection of ADP-ribosylation within these arrays 
is realized through biotinylated NAD and the subsequent application of fluorescently 
labeled avidin, as there are no antibodies available to identify mono-ADP-ribosylation.  
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Figure 3. Domain structure of ARTD10. 
ARTD10 protein composition is schematically shown together with the amino acid count. The RRM was found in 
silico with no available in vitro data yet. Caspase restriction sites mapped in this thesis at D406 by caspase-6 and 
at D581 by caspase-1 are indicated. The total length of the protein is 1025 amino acids. Names and binding 
regions of mono- and polyclonal antibodies are shown. RRM, RNA recognition motif; G-rich, glycine-rich region; 
Nuclear targeting, sequence responsible for nuclear import; NES, nuclear export sequence; E-rich, glutamate-rich 
region; UIM, ubiquitin interacting motif.  
 
ARTD10’s domain structure, with the exception of its catalytic domain at the C-
terminus, is rather unique within the ARTD group [Figure 3]. At the N-terminus 
ARTD10 has a putative RRM (11-85) followed by a glycine rich region, a combination 
which is also present in other RNA binding proteins (Burd and Dreyfuss, 1994).  In a 
further C-terminal glutamate rich region (588-697) (which is also responsible for the 
aberrant mobility on SDS-PAGE) one can find a nuclear export sequence (NES) as 
well as two functional ubiquitin interaction motifs (UIMs). Studies with Leptomycin B, 
a potent inhibitor of the nuclear export protein Crm1, revealed that the NES is 
functional. A nuclear targeting region was mapped to amino acids 435-528 and 
extensive live cell imaging experiments showed that ARTD10 shuttles between the 
nucleus and cytoplasm (Kleine et al., 2012). Moreover ARTD10 localizes to distinct 
cytoplasmic foci, which in part colocalize with the ubiquitin adapter molecule p62. 
The regulation of ARTD10 proofs to be rather complex as it is, like most other ART 
family members, a target of ubiquitination, phosphorylation, acetylation and also 
ADP-ribosylation. Yet despite the evidence that those modifications exist, little is 
known about their function and implication in the physiological role of ARTD10.  
 
As ARTD10 was discovered in a screen for interaction partners of MYC, binding to 
MYC and influence on MYC’s cellular functions was investigated. The interaction 
interface was mapped to amino acids 700-907, a region stretching into the catalytic 
domain of ARTD10. The same study revealed, that expression of ARTD10 inhibited 
MYC/HA-RAS-dependent transformation of rat embryo fibroblasts. This effect was 
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independent of ART activity, but was abolished when nuclear export was repressed 
by mutations in the NES. A similar effect was observed in 3T3-L1 murine fibroblasts, 
where the cells were unable to progress into S-phase when ARTD10 was 
overexpressed. Although these findings strongly suggested an overall implication of 
ARTD10 in cell growth or cell cycle control, overexpression in other cell lines, like 
HEK293 and U2OS, did not reduce cell numbers (Yu et al., 2005). 
 
 
4.2 Apoptosis 
4.2.1 Introduction to apoptosis 
Apoptosis is a regulated form of cell death in which the cell is actively broken down in 
apoptotic bodies, which subsequently can be phagocytized. The phenotype was 
originally observed and described by three scientists at the University of Aberdeen in 
the early 70s. In their publication in 1972 they proposed the term apoptosis, which 
originates from a Greek word describing “leaves falling of a tree” (Kerr et al., 1972). 
Apoptosis is important for ordered cell homeostasis in healthy tissues and during 
development, not only in the model organism Caenorhabditis elegans, but also for 
example in the differentiation of fingers and toes. Nowadays many more 
physiological processes are known, which are influenced by apoptosis. Defects in 
apoptosis pathways are implicated in the development of diseases, including cancer 
(Elmore, 2007; Lowe and Lin, 2000). 
The classic phenotype of apoptosis is characterized by shrinkage of the cell and 
nucleus (pyknosis), chromatin condensation and nuclear fragmentation (karyorrhexis), 
the so-called membrane-blebbing and finally the formation of apoptotic bodies. These 
morphologic changes were defined as the hallmarks of apoptosis, which were used 
to discriminate this process from the other two main forms of cells death: necrosis 
and autophagy. But as more and more intermediate forms of cell death became 
apparent, the focus shifted towards characterizing cell death forms by biochemical 
features rather than by the classic organization into the three groups mentioned 
above (Kroemer et al., 2009). In agreement with this, Table 2 shows an overview of 
biochemical processes involved in apoptosis and standard methods of detection.   
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Table 2. Biochemical features and detection methods of apoptosis [adapted from (Kroemer et al., 2009)]. 
Biochemical feature Methods for detection 
Activation of caspases  Colorimetric/fluorogenic substrate-based assays in live cells 
 Colorimetric/fluorogenic substrate-based assays of lysates in microtiter plates 
 
FACS/IF microscopy quantification with antibodies specifically recognizing the 
active form of caspases 
 
FACS/IF microscopy quantification with antibodies specific for cleaved caspase 
substrates  
 FACS/IF microscopy quantification with fluorogenic substrates 
 Immunoblotting assessment of caspase-activation state 
 Immunoblotting assessment of the cleavage of caspase products (e.g. ARTD1) 
ΔΨm dissipation Calcein-cobalt technique (FACS/IF microscopy) 
 FACS/IF microscopy quantification with ΔΨm -sensitive probes  
 Oxygen-consumption studies (polarography)  
MMP Colorimetric techniques to assess the accessibility of exogenous substrates to IM-embedded enzymatic activities 
 FACS-assisted detection of IMS proteins upon plasma membrane permeabilization 
 FACS-assisted detection of physical parameters of purified mitochondria  
 HPLC-assisted quantification of mitochondrial alterations in purified mitochondria 
 
IF microscopy colocalization studies of IMS proteins (e.g., Cyt c) with sessile 
mitochondrial proteins (e.g., VDAC1) 
 IF (video) microscopy with Cyt c-GFP fusion protein 
 Immunoblotting detection of IMS proteins (e.g., Cyt c) upon cellular fractionation  
Oligonucleosomal DNA  DNA ladders 
fragmentation FACS quantification of hypodiploid cells (sub-G1 peak)  
 TUNEL assays  
Activation of proapoptotic 
Bcl-2 family proteins 
IF microscopy localization studies 
Immunoblotting with conformation-specific antibodies  
Plasma membrane rupture  Colorimetric/fluorogenic substrate-based assays of culture supernatants in microtiter plates to determine the release of cytosolic enzymatic activities (e.g., LDH) 
 FACS quantification with vital dyes  
PS exposure FACS quantification of Annexin V binding  
ROS overgeneration FACS/IF microscopy quantification with ROS-sensitive probes  
ssDNA accumulation FACS quantification with ssDNA-specific antibodies  
Abbreviations: ΔΨm, mitochondrial transmembrane permeabilization; Cyt c, cytochrome c; FACS, fluorescence-
activated cell sorting; GFP, green fluorescent protein; HPLC, high-pressure liquid chromatography: IF, 
immunofluorescence; IM, mitochondrial inner membrane; IMS, mitochondrial intermembrane space; LDH, lactate 
dehydrogenase; MMP, mitochondrial membrane permeabilization; PS, phosphatidylserine; ROS, reactive oxygen 
species; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling; VDAC1, voltage-
dependent anion channel 1. 
 
The implication of apoptotic proteins, caspases and mitochondria as well as 
pathways that lead to apoptosis will be introduced in the next chapters. 
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4.2.2 Key players in apoptosis 
4.2.2.1 Caspases	  
Caspases are a family of proteases, which are involved in a huge variety of cellular 
processes, but are best known for their function in cellular apoptosis. The name 
‘caspase’ is an abbreviation of cysteine-dependent aspartate-directed proteases, 
describing their catalytic functionality. The founding member caspase-1 was originally 
named ICE (IL-1β converting enzyme), as it is required for the maturation of this 
cytokine (Thornberry et al., 1992). The connection to apoptosis was made when a 
homology to ced-3 (cell death protein-3) was discovered, a key component in the 
regulated cell death during Caenorhabditis elegans maturation (Yuan et al., 1993). 
As the family of ICE/ced-3 related proteins grew the nomenclature was unified in 
1996 and in humans it consists of 11 proteins (Alnemri et al., 1996; Fan et al., 2005). 
In regard to their structure and function these 11 proteases can be further subdivided 
into three groups [Table 3]. The so-called initiator caspases are characterized by 
their N-terminal protein-protein interaction domain, by which they are clustered upon 
apoptosis stimulation. They are the first to be activated and in turn cleave in a 
process called caspase cascade the effector caspases. The latter only have a very 
short N-terminal domain and are the proteases responsible for most of the apoptotic 
phenotype, as they cleave a large number of different cellular proteins (Taylor et al., 
2008). The third group of caspases encompasses the inflammatory caspases. These 
proteases are not involved in apoptosis at all, but rather function in inflammatory 
processes. 
 
Table 3. The human caspase family. 
Subfamily Role Members Domains P4 à P1 * 
I Initiator caspases Caspase-2 CARD DEHD 
  Caspase-8 DED LETD 
  Caspase-9 CARD LEHD 
  Caspase-10 DED  
II Executioner caspases Caspase-3  DEVD 
  Caspase-6  VEHD 
  Caspase-7  DEVD 
III Inflammatory caspases Caspase-1 CARD IEPD 
  Caspase-4 CARD WEHD 
  Caspase-5 CARD WEHD 
 Mediator of keratinocyte differentiation (Denecker et al., 2008) Caspase-14   
DED, death effector domain; CARD, caspase-recruitment domain; *amino acid consensus recognition motif 
(Thornberry et al., 1997)  
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All caspases are produced as inactive zymogens or pro-caspases. Activation occurs 
as mentioned above through oligomerization and subsequent reciprocal cleavage or 
cleavage by other members of the caspase family.  Apart from the N-terminal pro-
domain the structure of the caspases is similar throughout the family. Two domains 
separated by a small linker sequence will later on form the large (p20) and small 
(p10) subunit of the active caspase [Figure 4]. When the zymogen is processed the 
resulting p20 and p10 fragments form a heterodimer, which again combined with 
another dimer forms the active hetero-tetramer (Fuentes-Prior and Salvesen, 2004). 
The catalytic center of the caspases is located in the p20 subunit and features a 
highly conserved ‘QACXG’ motif (where X can be R, Q or D) with a cysteine in the 
middle, which is crucial for catalytic activity (hence their name) (Fan et al., 2005). 
 
 
Figure 4. Structural changes during caspase activation [adapted from (Clarke and Tyler, 2009)]. 
The domain structures of an inactive and active caspase are depicted. During maturation caspases are cleaved at 
two aspartic acids, resulting in the removal of the pro-domain and the separation of the large (p20) and small 
(p10) catalytic subunit. Subsequently two p20 subunits containing the catalytically essential ‘QACXG’ motif (X 
being R, Q or D) bind two p10 units to form the active hetero-tetrameric caspase.  
 
The substrate specificity is different in every caspase, although cleavage of many 
substrates is redundant [Table 3]. As caspases are proteases their cleavage sites 
were analyzed using the standard nomenclature from Schechter and Berger 
(Schechter and Berger, 1967). The amino acids surrounding the cleavage site are 
named and counted N-terminally P1, P2, P3 etc. whereas the C-terminal amino acids 
are marked with an apostrophe (P1’) [Figure 5].  
Although various exceptions complicate the identification of precise consensus 
sequences for target motifs of each caspase, all caspases prefer a glutamate at P3 
and the aspartate at P1, which led to their name (Thornberry et al., 1997; Timmer 
and Salvesen, 2007). Although the specific binding groove of caspases prefers an 
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aspartate at P1 to a glutamate with up to 4 magnitudes higher specificity, there are 
exceptions reported where substrates are cleaved following a glutamate (Krippner-
Heidenreich et al., 2001; Stennicke et al., 2000). Positions P4, P2 and P1’ are also 
important and differ for each caspase (Talanian et al., 1997). At position P1’ for 
example charged or bulky amino acids are known to inhibit restriction, whereas 
smaller amino acids seem not to interfere (Stennicke et al., 2000). More recent 
approaches even take the amino acid range from P10 to P10’ into account to specify 
caspase restriction sites. (Shen et al., 2010).  Commercial substrate peptides and 
inhibitors for caspases are available, which claim to target specifically each caspase. 
 
 
Figure 5. Nomenclature of the amino acid positions of caspase cleavage sites [adapted from (Shen et al., 
2010)]. 
The cleavage site nomenclature, originally developed by Schechter and Berger (Schechter and Berger, 1967), 
and the extended version are used to define and communicate the amino acid prevalence of different caspases. 
Amino acid frequencies in known caspase cleavage sites can be integrated in algorithms to predict and determine 
new sites. 
 
As mentioned earlier caspases are the key components in apoptosis by cleaving a 
variety of cellular proteins, which finally leads to the apoptotic phenotype (Martin and 
Green, 1995). Until now several hundred caspase substrates have been identified 
and many of those show either a gain- or a loss-of-function phenotype upon 
proteolytic processing, but the functional relevance of the cleavage remains unknown 
for most of the targets (Luthi and Martin, 2007; Taylor et al., 2008; Timmer and 
Salvesen, 2007). Nonetheless there is strong believe that most of them are targeted 
on purpose as a lot of caspase sites separate domain-containing parts of proteins 
and a great part of generated fragments are very stable (Johnson and Kornbluth, 
2008). 
There are several substrates, for which the function of proteolysis by caspases is 
understood in more detail. Lamins are targeted by caspase-6 and their breakdown 
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contributes to the condensation of chromatin and the subsequent breakdown of the 
nuclear envelope (Cowling and Downward, 2002; Takahashi et al., 1996). The 
decomposition of the cytoskeleton on the other hand is mediated by the cleavage of 
actin and fodrin (Janicke et al., 1998; Mashima et al., 1999). Two substrates and 
examples for the loss-of-function category are ARTD1 and ICAD, which are involved 
in the degradation of the DNA. ARTD1 as mentioned above is inactivated in its 
function as DNA repair enzyme by the processing through caspase-3 (Lazebnik et al., 
1994). ICAD is under normal physiological conditions the inhibitor of the 
endonuclease CAD (caspase-activated DNase). Upon cleavage by caspase-3 its 
binding capabilities are lost and active CAD translocates to the nucleus and cleaves 
the DNA in oligonucleosomal fragments (Liu et al., 1999; Sakahira et al., 1998). This 
finally leads to chromatin condensation and formation of apoptotic bodies, as the 
absence of CAD results in defects in those processes (Liu et al., 1997). 
Phosphatidylserine is a phospholipid normally found on the inner leaflet of the 
plasma membrane, where it is kept by a translocase (Verhoven et al., 1995). Its 
presentation on the outer membrane side during apoptosis is one of the early 
phenotypes in apoptosis. Although the exact mechanism controlling the 
externalization is unknown, it is at least partially caspase dependent (Ferraro-Peyret 
et al., 2002; Huigsloot et al., 2001). Its presentation to the surrounding cells is a key 
step in the prevention of inflammation due to secondary necrosis, as it stimulates 
macrophages to engulf the apoptotic cell and apoptotic bodies that are formed 
(Verhoven et al., 1995). The receptors T cell immunoglobulin mucin (TIM) proteins 1 
and 4 are responsible for PS binding and promote the signal in macrophages and 
dendritic cells (Santiago et al., 2007). In addition to this “eat-me” signal, other 
molecules on living cells, like CD31 or CD46, have the opposing effect and prevent 
phagocytosis (Brown et al., 2002; Elward et al., 2005). Figure 6 summarizes the 
apoptotic targets and their effect on cellular morphology. 
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Figure 6. Caspase mediated degradation of cellular integrity [adapted from (Taylor et al., 2008)]. 
The apoptotic phenotype of a cell is mediated by the activity of the effector caspases, which cleave a variety of 
proteins leading finally to the ordered cellular breakdown. Nuclear decomposition is promoted by cleavage of the 
DNA through CAD, phosphorylation and condensation of the chromatin by MST1 and nuclear envelope 
fragmentation due to the cleavage of lamins. ROCK1 and GRASP65 processing promotes GOLGI fragmentation 
and dissolves actin bundles, resulting in membrane destabilization. Also processes like cell-cell detachment, the 
exposure of phagocytic signals as well as the shutdown of translation due to cleavage of eIFs are effects of the 
proteolytic capabilities of caspases. CAD, caspase-activated DNase; ICAD, inhibitor of caspase-activated DNase; 
MST1, mammalian STE20-like protein kinase 1; ROCK1, Rho-associated protein kinase 1; GRASP65, Golgi 
reassembly-stacking protein 1; eIFs, eukaryotic initiation factor; ER, endoplasmic reticulum; MLC, myosin light 
chain; PS, phosphatidyl serine. 
 
4.2.2.2 BCL-­‐2	  family	  and	  IAPs	  
The initiated caspase cascade in apoptosis is a powerful process that is not 
reversible and therefore has to be tightly controlled. Two families of proteins 
contribute to this matter, the BCL-2 and IAP family, their founding members being 
discovered in the early 90s (Crook et al., 1993; Vaux et al., 1992). The connection to 
apoptosis was again made in Caenorhabditis elegans, where the single BCL-2 
homolog ced-9 was found together with the caspase homolog ced-3 (Hengartner and 
Horvitz, 1994). The B-cell lymphoma protein 2 family grew rapidly. Their members 
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are characterized by four B-cell homology (BH) domains, with BH3 as the only 
domain that is present in all members (Yin et al., 1994). According to the number of 
BH domains the family can be further subdivided into 3 groups. Members containing 
all four known domains, among those BCL-2 itself, are anti-apoptotic. The BH 
domains 1-3 as well as an additional transmembrane domain characterize the 
second group. Together with the last group, the BH3-only proteins, they are 
promoters of apoptosis [Figure 7]. 
 
 
Figure 7. Classification of the mammalian BCL-2 family members [adapted from (Strasser, 2005)]. 
BCL-2 family members are essential for the regulation of apoptosis. They can be subdivided by a combination of 
functional as well as structural features. Members containing all four BH domains are anti-apoptotic. The 
remaining pro-apoptotic proteins contain the BAX/BAK-like proteins, involved in mitochondrial membrane 
permeabilization, and the BH3-only proteins. The latter is the largest group and functions as intermediate between 
stress signals and apoptosis induction. Homology searches revealed additional family members, who are not 
listed here, as a requirement or involvement in apoptosis induction or prevention has yet to be shown. BCL-2, B-
cell lymphoma 2; BAX, BCL-2-associated X protein; BAK, BCL-2-antagonist/killer; BAD, BCL-2-antoganost of cell 
death; BIK, BCL-2-interacting killer; BID, BH3-interacting domain death antagonist; BIM, BCL-2-interacting 
mediator of cell death; PUMA, p53-upregulated modulator of apoptosis. 
 
The BH1-3 group of proteins is key to induction of mitochondria-dependent apoptotis 
by controlling their outer membrane permeability (Martinou and Green, 2001). As 
mentioned above they all contain the BH1-3 as well as a hydrophobic 
transmembrane (TM) domain. BAK (BCL-2 antagonist killer) is localized in the outer 
membrane of mitochondria, whereas the TM domain of BAX (BCL-2-associated 
protein X) is hidden inside the protein, leading to its cytosolic localization (Suzuki et 
al., 2000). Both are essential for apoptosis in response to several death stimuli and in 
normal tissue development (Lindsten et al., 2000; Wei et al., 2001). The precise 
initiation of outer membrane permeabilization by BAX/BAK however is not well 
understood. The 3D structure of BAX revealed α-helices similar to pore forming 
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bacterial toxins and the translocation domain of diphtheria toxin (Suzuki et al., 2000). 
Interestingly this structure is also conserved in anti-apoptotic family members, like 
BCL-2 and BCL-XL (Muchmore et al., 1996). The deletion or exchange of the specific 
α-helix in those proteins in vitro or by caspases completely changes their function to 
promotion of apoptosis (Cheng et al., 1997; George et al., 2007).  
The current understanding of the activation of BAX is that upon certain apoptotic 
stimuli, be it stress signals or toxic agents, its conformation is changed leading to the 
exposure of its transmembrane domain and the subsequent insertion into the 
mitochondrial outer membrane (Nechushtan et al., 1999). Especially BH3-only 
proteins are believed to influence this structural modification of BAX, which is 
strengthened by experiments with BH3 peptides derived of BIM and BID or tBID 
directly (Desagher et al., 1999; Gavathiotis et al., 2008; Walensky et al., 2006). 
Following insertion BAX oligomerizes with BAK and itself to form pores in the outer 
mitochondrial membrane leading to the efflux of apoptosis promoting proteins like 
cytochrome C or SMAC/DIABLO (Kroemer et al., 2007; Vaux, 2011). This process is 
again strongly promoted by the BH3-only proteins BID/BIM (Eskes et al., 2000; 
Kuwana et al., 2002). Opposing the BH1-3 proteins, the anti-apoptotic BCL-2 like 
proteins inhibit pore formation by binding to BAX/BAK [Figure 7] (Cheng et al., 2001). 
They contain all four known BH domains and a transmembrane domain, which leads 
to a localization at mitochondria, the nucleus and the endoplasmatic reticulum (Reed, 
2006).  
 
Most proteins containing multiple BH domains seem to interact with members of the 
BH3-only group (Cheng et al., 2001). With until now 18 discovered genes in humans 
this group is the largest in the BCL-2 family (Reed et al., 2004). They function as 
regulators and transmitters of apoptotic signals, by inhibiting anti-apoptotic proteins 
or in the case of BIM/BID by stimulating the pro-apoptotic proteins BAX/BAK 
(Lomonosova and Chinnadurai, 2008). They are therefore classified as “sensitizers” 
or direct “activators” (Martinou and Youle, 2011). The BH3-proteins themselves are 
activated and controlled by different mechanisms. NOXA as well as PUMA are 
inducible by the transcription factor p53, which is a mediator of DNA damage 
associated apoptosis (Clarke et al., 1993; Lowe et al., 1993; Nakano and Vousden, 
2001; Oda et al., 2000). BID is cleaved by caspases or calpains to the shorter form 
tBID, is then myristoylated and subsequently integrates into the outer mitochondrial 
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membrane were it facilitates the oligomerization of BAX (Desagher et al., 1999; 
Strasser, 2005). Additional ways of regulation are the stress-induced 
dephosphorylation and subsequent stabilization of BIM or the Ca2+-dependent 
dephosphorylation of BAD (Puthalakath et al., 2007; Wang et al., 1999). 
 
 
A second group of proteins involved in the negative regulation of cell death is the 
inhibitor of apoptosis (IAP) family (Shi, 2004a). They were originally discovered in the 
baculoviral genome, which led to the name of their common domain, the baculoviral 
IAP repeat (BIR) (Crook et al., 1993). These BIR domains are stretches of about 70 
amino acids with a cysteine/histidine containing core motif (Hinds et al., 1999). They 
occur in repeats of 1-3 domains, facilitate protein-protein interactions and are 
essential for the anti-apoptotic function of IAPs (Srinivasula and Ashwell, 2008). In 
addition to the BIR domains the best studied human IAPs c-IAP1, c-IAP2 and XIAP 
contain a RING (really interesting new gene) domain, which confers E3 ligase activity, 
and in the case of the c-IAPs an additional CARD (caspase activation and 
recruitment domain) [Figure 8] (Srinivasula and Ashwell, 2008). All IAPs bind several 
caspases through their BIR2/3 domains, but only XIAP is able to directly inhibit the 
executioner caspase 3 and 7 as well as the initiator caspase 9 using two different 
interaction sites (Eckelman and Salvesen, 2006; Eckelman et al., 2006). The direct 
inhibition by c-IAPs was only shown in vitro so far and is about 100 fold weaker than 
the effect of XIAP (Deveraux and Reed, 1999). The BIR1 domain is an exception to 
the binding pattern of BIR2/3, as it confers binding to mainly signaling molecules 
(Srinivasula and Ashwell, 2008). Although the CARD domain in other proteins is 
linked to the binding of apoptotic and inflammatory proteins containing the same 
domain, its function in the c-IAPs is not well understood. Recently it was reported that 
the CARD domain has an auto-inhibitory effect on the RING domain, controlling the 
enzymatic functions of c-IAP1/2 (Lopez et al., 2011). This E3 ligase activity is at the 
moment a focus of research and several groups reported not only implications in 
apoptosis prevention, but also in regulating signaling cascades. c-IAPs as well as 
XIAP ubiquitinate caspase 3 and/or 7 leading to their degradation. c-IAP1/2 in 
addition ubiquitinate their inhibitor SMAC/DIABLO and thereby contribute to its 
turnover (Choi et al., 2009; Hu and Yang, 2003; Suzuki et al., 2001). SMAC/DIABLO 
originally identified in 2000 is released from the mitochondrial inner membrane space 
Introduction  22 
and binds to IAPs through a four amino acid long N-terminal IAP binding motif (IBM) 
thereby reverting their inhibitory effect (Chai et al., 2000; Du et al., 2000; Shi, 2002; 
Verhagen et al., 2000). Interestingly the same functional binding peptide can be 
found in proteolytically activated caspase-9, leading to opposing effects in activation 
of the caspase cascade, as caspase-9 is inhibited first by binding to XIAP until 
SMAC/DIABLO replaces it (Srinivasula et al., 2001). Ubiquitination by IAPs not only 
confers degradation, but c-IAP1/2 also seem to play a role in different pathways 
involved in inflammation and apoptosis, like NF-κB and MAPK signaling, by K63-
linked ubiquitination of key proteins, leading to a binding scaffold for other proteins 
(Bertrand et al., 2008; Li et al., 2002; Matsuzawa et al., 2008; Varfolomeev et al., 
2008). 
 
 
Figure 8. The inhibitor of apoptosis family [adapted from (Riedl and Shi, 2004)]. 
Schematic representations of the most prominent members of the inhibitor of apoptosis (IAP) family are shown. 
The conserved sequence that is important for binding of caspase-3 and -7 is marked in red in all three proteins. In 
contrast only the BIR3 domain of XIAP is able to bind and inhibit caspase-9. The roles of the CARD and RING 
domain have yet to be elucidated, but it seems that the E3-ligase function of the RING domain is involved in 
protein degradation and the CARD in controlling its activity. c-IAP, cellular IAP; XIAP, X-linked IAP; BIR, 
baculoviral IAP repeat; CARD, caspase-recruitment domain. 
 
4.2.3 Intrinsic pathway 
Two major pathways lead to the induction of apoptosis, which are also partly linked to 
each other. Signals from within the cell activate the intrinsic pathway of apoptosis, 
with the BCL-2 family and the mitochondria as key players [Figure 9]. The signals 
can comprise all sorts of ‘stress signals’ ranging from environmental factors like 
hypoxia or growth factor withdrawal to extensive DNA damage or disturbance in the 
protein biosynthesis (Pereira and Amarante-Mendes, 2011). Depending on the 
stimulus different sensors are involved in finally promoting mitochondrial outer 
membrane permeabilization, which marks the point of no return. Certain cytotoxic 
substances can damage the mitochondria themselves; other signals involve the 
Introduction  23 
members of the BCL-2 family. DNA damage for instance activates the transcription 
factor p53, which enhances transcription of a wide variety of genes including the pro-
apoptotic PUMA, BAX and BID, but at the same time has a repressing effect on anti- 
BCL-2 transcription (Nakano and Vousden, 2001; Vousden and Lu, 2002; Wu et al., 
2001). Although different routes are taken, ultimately the mitochondria are damaged, 
either by pore formation through the BCL-2 family members BAX/BAK alone or in 
combination with the so-called permeability transition pore complex. The latter is a 
multiprotein complex spanning the outer and inner mitochondrial membrane and is 
involved in the loss of inner mitochondrial membrane potential.  Core subunits of this 
large complex are the voltage-dependent ion channel (VDAC), the adenine 
nucleotide translocase (ANT) and cyclophilin D (Zamzami et al., 2005). Its role in 
apoptosis is not fully understood, but it seems that opening of this channel leads to 
efflux of Ca2+ and solutes smaller than 1.5 kD, influx of water and finally swelling and 
membrane rupture (Orrenius et al., 2011). The pore formed by multimerization of 
BAX/BAK on the other hand only opens the outer mitochondrial membrane, followed 
by the efflux of proteins from the mitochondrial inter-membrane space, with pro-
apoptotic proteins, like cytochrome c, AIF, endonuclease G, SMAC/DIABLO and 
HtrA2/OMI among them (Patterson et al., 2000; Wei et al., 2001). Cytochrome c, 
normally part of the electron transport chain in the inter-membrane space (IMS), is 
commonly recognized as the main factor promoting apoptosis (Bernardi and Azzone, 
1981). Upon release to the cytoplasm cytochrome c binds dATP as well as apoptotic 
protease activating factor 1 (APAF-1) in a heptameric structure called the 
apoptosome [Figure 11] (Acehan et al., 2002; Yuan et al., 2010; Zou et al., 1999). A 
conformational change in the APAF-1 and subsequent exposure of a CARD domain 
promotes the CARD-CARD interaction with pro-caspase-9 and subsequent auto-
activation of the latter. The presence of cytochrome c in the cytoplasm alone is 
enough to trigger apoptosis (Vaux, 2011). The active caspase-9 as initiator caspase 
now processes effector caspases triggering the caspase cascade. 
Other pro-apoptotic factors released from IMS like the flavoprotein apoptosis-
inducing factor (AIF) and endonuclease G are involved in the caspase independent 
breakdown of genomic DNA (Cande et al., 2002; Kroemer and Martin, 2005; Li et al., 
2001). SMAC/DIABLO as well as HtrA2/OMI function through inhibition of the IAP 
family members (Verhagen et al., 2000; Verhagen et al., 2002). Opposed to 
SMAC/DIABLO, the contribution of HtrA2 to IAP inhibition is currently on debate.  
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The apoptotic effects of the serine protease HtrA2 could be due to the sudden 
protease activity in the cytoplasm, whereas the IAP inhibition plays a minor role, 
which would explain the missing effect on apoptosis in mice lacking HtrA2 (Saelens 
et al., 2004; Vaux, 2011). 
 
 
Figure 9. The intrinsic and extrinsic induction of apoptosis [adapted from (Long and Ryan, 2012)]. 
The two pathways that lead to apoptosis are shown in this diagram. The intrinsic pathway is triggered by cell 
stress like DNA damage, nutrition deprivation or oxidative stress, incidents that are sensed by proteins of the 
BCL-2 family. Oligomerization of BAX/BAK leads to mitochondrial membrane permeabilization (MMP) and the 
subsequent release of apoptotic mediators such as cytochrome c and SMAC/DIABLO. The latter inhibits the anti-
apoptotic XIAP, whereas the ATP-dependent binding of cytochrome c to APAF-1 and pro-caspase-9 results in the 
formation of the apoptosome, a complex that activates downstream effector caspases. External death stimuli 
through receptors like FAS and TRAIL-R induce a homologous complex through binding of adapter molecules like 
FADD and the initiator pro-caspase-8. This death-inducing signaling complex (DISC) triggers the auto-activation 
of caspase-8 and the subsequent progression of the caspase cascade. The BCL-2 family member BID connects 
the two pathways as it promotes BAX oligomerization at the mitochondria after cleavage by caspase-8. 
SMAC/DIABLO, second mitochondria-derived activator of caspase/Direct IAP-binding protein with low pI; XIAP, 
X-linked inhibitor of apoptosis FADD, FAS-associated protein with a death domain; BAX, BCL2-associated X-
protein. 
 
4.2.4 Extrinsic pathway 
The extrinsic pathway leading to apoptosis relies on members of the TNF-receptor 
family to initiate the death signal, like CD95/FAS, TNF-R1 or TRAIL receptors. These 
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receptors contain a cysteine-rich extracellular and a cytoplasmic death domain and 
are involved in immunology, differentiation and survival (Debatin and Krammer, 2004; 
Gaur and Aggarwal, 2003). The TNF-R1 and FAS pathways were focus of research 
over several years. Both are activated through trimerization when the specific trimeric 
ligands TNF or FASL bind and subsequently stimulate protein interactions at their 
death domains (DD). FASL/FAS recruit the FAS-associated death domain protein 
(FADD), whereas TNF/TNF-R recruit TNF-R1-associated death domain protein 
(TRADD), both of which are adapter molecules to pro-caspase-8 or its homolog pro-
caspase-10 through their death effector domains (DED) (Chinnaiyan et al., 1995; Hsu 
et al., 1995). At this point a regulatory mechanism can come into action involving the 
cellular FLICE-like inhibitory protein (cFLIP), which also binds via a DED and thereby 
prevents the caspase recruitment, a mechanism that is also exploited by viruses and 
tumor cells (Benedict et al., 2002; Krueger et al., 2001; Shirley and Micheau, 2010). 
The assembled complex of receptor, adapter and caspase is termed death-inducing 
signaling complex (DISC) (Wilson et al., 2009). Similar to the before mentioned 
apoptosome, caspases are brought into close proximity and are subsequently auto-
activated, resulting in the initiation of the caspase cascade (Salvesen and Dixit, 1999; 
Shi, 2004b). 
For FASL/FAS complexes different modes of activation were described depending on 
the cell types. In type I cells the pathway follows the standard route also seen for 
TNF-R1 or TRAIL-R. Type II cells are defined by an involvement or rather 
amplification through the intrinsic pathway. In this case DISC assembly is less 
prominent and activated caspase-8, instead of initiating the caspase cascade, 
cleaves the pro-apoptotic BID to tBID. tBID in return integrates into the mitochondrial 
membrane, recruits BAX and leads to the activation of the intrinsic apoptosis 
pathway (Fulda et al., 2001; Scaffidi et al., 1998). 
 
4.3 Inflammasome 
The inflammasome is a multimeric complex, which leads to the activation of 
inflammatory caspases, the third group of the caspase family. It is part of the innate 
immune response and forms upon encounter of pathogen-associated molecular 
patterns (PAMPs) as well as danger-associated molecular patterns (DAMPs). The 
result of its activation is the processing of pro-inflammatory cytokines like IL-1β and 
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IL-18 by caspases and their subsequent secretion, the mechanism of which is still 
unknown [Figure 10]. Due to the involvement in inflammation and the homology to 
the apoptosome, Martinon et al. coined the term inflammasome in 2002 [Figure 11] 
(Martinon et al., 2002). Host defense and the decision between foreign and self is 
mediated in the innate immune response through a variety of receptors, 
encompassing the membrane spanning families of Toll-like receptors (TLRs) and C-
type lectin receptors (CLRs) as well as the cytosolic RIG-I-like receptors (RLRs) and 
NLRs (nucleotide-binding-and-oligomerization domain [Nod] and leucine-rich-repeat-
containing receptors), with members of the latter being part of inflammasomes 
(Bauernfeind et al., 2011a). Other families, like the TLR or TNFR family, promote 
expression of inflammasome components as part of a priming step (Bauernfeind et 
al., 2009).  
The human NLR family until now contains 22 members with the defining leucine rich 
repeats (LRRs) and NACHT domain (also NOD [nucleotide-binding-and-
oligomerization domain] or NBD [nucleotide-binding domain]), which are classified 
into 5 groups according to their additional domains: The NLRA group contains an 
acidic activation domain, NLRBs a BIR domain, and NLRCs a CARD domain 
whereas NLRPX lack a defined domain. The largest subgroup, NRLPs, comprises of 
proteins with a C-terminal pyrin domain, another member of the death fold protein-
protein interaction domains (Fairbrother et al., 2001; Ting et al., 2008a). Most of the 
NLRs are involved in diverse inflammatory signaling processes, whereas NLRP1, 
NLRP3 and NLRC4 are key components of different inflammasomes. The LRRs of 
these proteins are thought to be the sensing part of the protein, although no direct 
binding to an activator could be shown until now (Bella et al., 2008). The NACHT 
domain resembles a motif of APAF-1, the central apoptosome unit, binds ATP and is 
thought to oligomerize upon this interaction, which is key to the activation of the 
caspases [Figure 11] (Bauernfeind et al., 2011a; Duncan et al., 2007). As only the 
ARTC subgroup contains a CARD domain to recruit inflammatory caspases directly, 
an adapter molecule is needed to propagate the signal for NLRP1 and NLRP3, 
respectively. PYCARD (or ASC [apoptosis-associated speck-like protein containing a 
CARD]), a protein containing a pyrin domain (PYD) as well as a CARD, was found as 
a promoter of apoptosis (Masumoto et al., 1999; McConnell and Vertino, 2000). A 
few years later the connection to the inflammasome was made and ASC has turned 
out to be involved in all known inflammasomes, including NLRC4, for which the exact 
Introduction  27 
mechanism still has to be discovered, as NLRC4 lacks the PYD (Agostini et al., 2004; 
Manji et al., 2002; Mariathasan et al., 2004; Srinivasula et al., 2002). 
 
 
Figure 10. Priming and activation of the NLRP3 inflammasome [adapted from (Horvath et al., 2011)]. 
The NLRP3 inflammasome activation is a two-step mechanism. At first inflammatory signaling through NF-κB 
stimulates the expression of NLRP3 itself and the proteolytic target of caspase-1 IL-1β. Upon sensing a second 
signal such as ROS, potassium efflux or lysosomal damage, by mechanisms yet to be discovered, NLRP3 
oligomerizes with ASC and pro-caspase-1. The assembled inflammasome results in the proximity-induced 
activation of caspase-9 and subsequent cleavage of IL-1β. NF-κB, nuclear factor ‘kappa-light-chain-enhancer’ of 
activated B-cells; IL1β, interleukin-1β; ROS, reactive oxygen species; ASC, apoptosis-induced speck-like protein. 
 
The NRLP1 inflammasome was the first to be described to form apoptosome-like 
structures (Martinon et al., 2002). Unlike other NLRs, NLRP1 also contains a FIIND 
(function to find domain) and CARD in addition to the classifying PYD, which allows 
the direct binding of caspases (Martinon et al., 2002). It is activated by lethal toxin 
(LT) of Bacillus anthracis as well as the peptidoglycan muramyl dipeptide (MDP), 
which is a component of bacterial cell walls (Faustin et al., 2007; Hsu et al., 2008). In 
the presence of MDP or LT NRLP1 forms oligomers, the basis for the inflammasome, 
and recruits caspase-5 through its CARD domain as well as caspase-1 through the 
collaboration with ASC (Martinon et al., 2002). A direct interaction between NRLP1 
and its activators could not be shown, but recent work suggests that another family 
member, NLRC2, is also involved in cooperation with NLRP1 (Hsu et al., 2008). 
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Regulation of NLRP1 seems to be realized through binding of BCL-2 and BCL-XL to 
its LRR and subsequent inhibition of caspase-1 activation, which represents another 
parallel to apoptosis (Bruey et al., 2007).  
 
 
Figure 11. The apoptosome and inflammasome are homologue structures [adapted from (Ting et al., 
2008b)]. 
The two proposed heptameric complexes involved in the inflammatory response to DAMPs/PAMPs and in the 
intrinsic apoptotic pathway are similar. Both structures contain a protein capable of ATP-dependent 
oligomerization (APAF-1 and NLRP3) and a caspase as effector. The apoptosome (a) assembles upon binding of 
cytochrome C to APAF-1 and pro-caspase-9, leading to activation of the latter and finally to apoptosis. The 
inflammasome (b) relies on NLRP3 as sensor of DAMPs/PAMPs and contains in addition the adapter molecule 
ASC and pro-caspase-1 in its functional state. The subsequent processing of IL-1β and IL-18 further enhances 
the inflammatory milieu surrounding the cell. CARD, caspase-recruitment domain; NBD, nucleotide-binding 
domain; DAMPs/PAMPs, danger/pathogen associated molecular patterns; LRR, leucine-rich repeats; ASC, 
apoptosis-induced speck-like protein. 
 
 Although the NLRP1 inflammasome was the first to be described, the NLRP3 
inflammasome is the most extensively studied, most likely due to its broad range of 
activators. These include PAMPs, like bacterial RNA, bacterial cell wall components 
and pore forming toxins as well as DAMPs, like metabolites, aggregates or crystals 
(Bauernfeind et al., 2011a; Kanneganti et al., 2006; Martinon et al., 2004). The latter 
includes endogenous deposits like uric acid crystals and amyloid β fibrils and 
exogenous materials like asbestos, silica and alum (Dostert et al., 2008; Eisenbarth 
et al., 2008; Halle et al., 2008; Hornung et al., 2008; Martinon et al., 2006). Therefore 
it is believed that the NLRP3 inflammasome acts as a defect and disturbance sensor 
in general. As part of its regulation, its expression is controlled via the NF-κB 
pathway and relies on activation by other pattern recognition receptors like TLRs 
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(Bauernfeind et al., 2009). NLRP3 lacks a CARD and the propagation of the signal to 
caspases happens through PYD-PYD interactions with ASC. The mechanism on the 
other hand by which NLRP3 detects its various activators is still not clearly 
understood, but three main theories are being pursued [Figure 10]. The first involves 
the purinergic receptor P2X7, which upon ATP binding opens a pore together with its 
partner protein pannexin-1 (Ferrari et al., 2006; Pelegrin and Surprenant, 2006). The 
resulting potassium efflux or influx of DAMPs/PAMPs seem to activate the NLRP3 
inflammasome (Kanneganti et al., 2007; Petrilli et al., 2007). Although it could explain 
the sensing of for instance necrotic cell death by the inflammasome, the ATP levels 
needed in vitro are much higher than levels released in vivo (Bauernfeind et al., 
2011a). The second observation to explain NLRP3 activation was made in 
phagocytes. Upon engulfment of DAMPs, such as silica crystals, lysosomal rapture 
can occur with leakage of compounds like cathepsin B into the cytosol triggering 
NLRP3 activation (Hornung et al., 2008). This mechanism defines the inflammasome 
as watchman of lysosomal integrity. In a third scenario reactive oxygen species were 
proposed as common denominator of NLRP3 activation, but recent findings suggest 
that this occurs most likely by affecting gene transcription (Bauernfeind et al., 2011b; 
Dostert et al., 2008; Zhou et al., 2011). 
The third of the well-studied NLR inflammasomes utilizes the CARD containing 
NLRC4 as signal sensor, which directly binds to caspase-1 (Poyet et al., 2001). It is 
activated by flagellin and components of the type III secretion system of gram- 
bacteria, which both exhibit a common motif, but similar to NLRP1 and NLRP3 direct 
interaction could not be proven (Franchi et al., 2006; Miao et al., 2006; Miao et al., 
2010). Surprisingly NLRC4 discriminates between flagellins, e.g. Escherichia coli 
flagellin fails to activate, which is explained by the importance of discriminating 
between commensal and pathogenic bacteria (Ren et al., 2006). 
In addition to the receptors of the NLR family another receptor was postulated in 
2008, when it was observed that double-stranded DNA (dsDNA) led to the 
processing of IL-1β without the involvement of NLRP3/NLRC4 (Muruve et al., 2008). 
The responsible protein AIM2 (absent in melanoma 2), a member of the PYHIN 
(pyrin domain and HIN domain containing) family, was identified a year later 
(Hornung et al., 2009). This cytosolic protein directly binds dsDNA with its HIN-200 
domain and ASC through the PYD, which makes it so far the only known member of 
the inflammasome sensors directly binding to its activator (Fernandes-Alnemri et al., 
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2009). As it contains no oligomerization domain in contrast to the NLRs, the 
assembly of the inflammasome is thought to be due to the multiple binding sites in 
the DNA polymer. This is strengthened by the observation, that shorter fragments of 
dsDNA are unable to trigger the inflammasome activation (Roberts et al., 2009). 
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5 Results & Discussion 
5.1 ARTD10 and cell proliferation 
ARTD10 was discovered only recently and therefore the work in our group so far was 
focused mainly on the basic characterization, like chromosomal localization, gene 
organization, domain structure and catalytic mechanism. Apart from those important 
findings, experiments with ARTD10 in rat embryo fibroblasts (REFs) showed a 
potential for inhibition of fibroblast transformation by MYC/HA-RAS. This was 
dependent rather on nuclear export then on catalytic activity. In addition 
overexpression of ARTD10 in 3T3-L1 murine fibroblasts led to failed G1/S transition. 
Although HEK293 and U2OS cells were unaffected, HeLa cells displayed a similar 
result in colony formation assays (Schuchlautz, 2008; Yu et al., 2005). To further 
elucidate the role of ARTD10 in cell proliferation HeLa cells with an incorporated 
inducible expression system were used in this work. 
 
5.1.1 Modell system: HeLa Flp-In T-Rex 
The Invitrogen Flp-In T-Rex system is designed to integrate a target gene at a 
specific site in the genome of a cell under the control of a tetracycline, i.e. 
doxycycline inducible promoter. Directed integration is achieved by the use of the Flp 
recombinase, which recognizes FRT sites in the expression vector and an integrated 
FRT site in the host cell. In a first step the latter has to be introduced into the cell 
using the pFRT/lacZeo vector. Cells were screened for a single integration and 
analyzed for a normal phenotype, as this insertion is not directed and can disrupt 
essential parts of the genome. The resulting Flp-In cell line contained a single FRT 
site and was Zeocin resistant. To complement the cells to be able to use a 
doxycycline controlled expression system, a TET repressor vector was additionally 
transfected and cells that propagated this pcDNA6/TR were selected with 
Blasticidin S. This cell line is now referred to as the Flp-In T-Rex host cell line and 
can be used for inducible expression of the desired target protein. A scheme of the 
further procedures is depicted in Figure 12A. There are different expression vectors 
containing the FRT site that are compatible with this modular system. The vector 
pcDNA5/FRT/TO was used in here. A CMV promoter containing TET operator sites 
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to which the TET repressor binds controlled the expression of the target gene. It was 
transfected together with the plasmid encoding the recombinase, which then 
promoted integration of the transgene into the FRT site in the genome. It thereby 
disrupted the Zeocin ORF and instead resulted in a hygromycin resistance, by which 
cells with successful integration could be selected. The complete system could now 
be activated by the addition of doxycycline, a tetracycline antibiotic that binds to the 
TET repressor, induces a conformational change and thereby prevents binding to 
DNA. The advantage of the Flp-In T-Rex system over other stably integrated 
expression vectors is the single targeted insertion. As the impact of the integration on 
the genome and the cell itself is explored prior to the integration of the target protein 
all resulting stable cell lines have the same background. The variation between 
clones is kept to a minimum and the establishment of single clones could even be 
omitted. S. Taylor from the University of Manchester provided the HeLa Flp-In T-Rex 
(HFT) cell line used here. 
 
The influence of ARTD10 on cell growth and transformation was dependent on the 
cell system and seemed to be in part dependent on either the catalytic activity or a 
functional NES (Schuchlautz, 2008; Yu et al., 2005). Therefore different ARTD10 
constructs were used to generate stable cells [Figure 12b]. The mutation of glycine at 
position 888 to a tryptophan (G888W or GW) renders the wild type protein (wt) 
inactive, whereas the replacement of three leucines to alanines abolishes nuclear 
export (Kleine et al., 2008; Yu et al., 2005). Changing all 9 lysines (ΔK) leaves 
ARTD10 unable to be ubiquitinated, whereas the mutation of the UIMs (ΔUIM) leads 
to the loss of K63-linked ubiquitin binding (Chauvistré, 2008; Milke, 2007). The 
ARTD10 construct lacking the amino acids 219-502 (Δ219-502) misses the glycine-
rich region, a feature that is commonly found in RNA binding proteins [see Figure 
3](Burd and Dreyfuss, 1994; Dreyfuss et al., 1993).  
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Figure 12. Establishing HeLa cell lines inducibly expressing ARTD10. 
(A) Schematic representation of the workflow to generate a Flp-In T-Rex expression cell line using the vector 
pcDNA5/FRT/TO. The co-transfection of the recombinase encoding vector pOG44 leads to an integration of the 
expression vector into the FRT site of the host cell. Due to this incorporation the lacZ-Zeocin reading frame is 
destroyed whereas an hygromycin reading frame is established, rendering the cells now Zeocin sensitive and 
hygromycin resistant. The expression of the target gene is achieved by addition of doxycycline an antibiotic that 
inactivates the Tet-repressor blocking the CMV promoter. 
(B) Table describing the modifications made in ARTD10 constructs and the resulting effect on the protein. AA, 
amino acid 
(C) Expression test of all established HeLa Flp-In T-Rex ARTD10 cell lines. Of each construct two different 
clones (c) were induced for expression with 1 µg/ml doxycycline (dox) and analyzed via SDS-PAGE and western 
blot using the polyclonal E09 antibody. An α-tubulin antibody was used as loading control. 
(D) Time course experiment with wt3 cells induced for expression of ARTD10 using 1 µg/ml doxycycline for the 
indicated times. The samples were analyzed via SDS-PAGE and western blot using the polyclonal E09 antibody. 
Tubulin was detected as loading control. 
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(E) Dose-response experiment with GW4 cells. The indicated amounts of doxycycline were used to induce 
expression of ARTD10 for 16 hours. The samples were analyzed via SDS-PAGE and western blot using the 
polyclonal E09 antibody. Tubulin was detected as loading control. 
 
 
After transfection and integration of the pcDNA5/FRT/TO constructs single HFT cell 
clones were established for every construct. Throughout this work the HFT lines are 
named using the abbreviations introduced above indicating the protein that was 
expressed and the clone number. Unnumbered lines represent the polyclonal cell 
population. Although the Flp-In T-Rex system, due to the directed single integration 
site of the transgene, should result in a homogenous cell population after integration, 
the single clones were established to nonetheless analyze possible differences 
between individual clones. Expression of the proteins was tested by SDS-PAGE and 
western blotting with a polyclonal antibody as all available monoclonal antibodies 
available during the initial characterization of the HFT clones recognized ARTD10 in 
the region missing in the Δ219-502 construct. All clones showed the expected 
ARTD10 band of 150 kD and a comparable expression level except for ARTD10-
Δ219-502, which ran at about 110kD [Figure 12C]. The 40 kD higher molecular 
weight of ARTD10 compared to the calculated theoretical weight is thought to be due 
to the highly positive charged glutamate-rich region ranging from amino acid 588 to 
697. Comparing the expression levels between the constructs and clones it can be 
stated that at the level of protein production the Flp-In T-Rex system is highly 
constant. The slightly weaker signal for the ARTD10-Δ219-502 could be due to the 
polyclonal antibody used, as it might also detect epitopes in the deleted region. Only 
minimal differences in protein expression could be observed and qualified this 
system as a tool to study the impact of different proteins on the cells. It is worth 
noting that the endogenous level of ARTD10 in HeLa cells is very low and with 
currently available antibodies the detection on a western blot of whole cell lysates 
was not possible, which explained the lack of a band in the uninduced samples 
[Figure 12C]. Dynamics of the expression level were explored using wt3. Therefore 
the protein levels, following either variations of the induction time [Figure 12D] or the 
quantity of doxycycline used, were monitored [Figure 12E]. The amount of ARTD10 
increased with time, with first traces being detectable by western blotting after 4 
hours of induction. The manufacturer’s guide recommended the initial use of 1 µg/ml 
tetracycline to induce expression of the protein of interest. As the analogue 
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doxycycline has a half-life of 48h, which is double the half-life of tetracycline, it was 
used in these experiments. The titration of doxycycline in a culture with GW4 cells 
showed detectable levels of ARTD10 with as low as 10 ng/ml and a dependence on 
the doxycycline quantity ranging up to 200 ng/ml [Figure 12E]. This concentration 
was used in all experiments if not indicated otherwise, to ensure constant expression 
even over longer time periods, taking into account the former mentioned half-life of 
doxycycline.  
ARTD10 was reported to be preferentially cytoplasmic due to its NES. Further 
experiments revealed, that it extensively shuttles between the nucleus and cytoplasm 
(Kleine et al., 2012). The region responsible for the necessary nuclear import was 
localized to a part of ARTD10 encompassing amino acids 435-528. The functional 
NES is dependent on the Crm1 export receptor, as its inhibitor Leptomycin B leads to 
nuclear accumulation of ARTD10 due to the NLS region (Fornerod et al., 1997; Yu et 
al., 2005). HeLa Flp-In T-Rex cells expressing wilt-type or mutant ARTD10 were 
subjected to immunofluorescence analysis to check for changes in the subcellular 
localization [Figure 13]. In addition Leptomycin B was used to ensure the functionality 
of the NES and to facilitate the localization analysis by blocking one component 
responsible for the localization. Staining of Δ219-502 was unfortunately not possible, 
as the polyclonal antibody was not specific enough for immunofluorescence and the 
epitope recognized by the 5H11 antibody lies within the deleted region. The 
localization of this construct would have been interesting, as a part of the proposed 
nuclear localization signal is missing. 
 
All constructs except for ΔNES showed a similar localization with the majority of the 
protein staining in the cytoplasm, a finding that was in line with results obtained from 
transient expression experiments [Figure 13]. Also as expected the ARTD10 without 
functional NES was distributed equally or with a preference for the nucleus, varying 
slightly in each individual cell. Upon Leptomycin B treatment all constructs showed 
localization comparable to the ΔNES construct. The residual staining in the 
cytoplasm could be either due to the continuous overexpression of the protein or a 
relatively weak nuclear targeting. In addition ARTD10 localized to specific dots in 
cells, the function of which are not fully understood. Colocalization experiments 
however rule out RNA associated structures like P-bodies and stress granules as 
well as Golgi, ER and endosomes. The poly-ubiquitin adapter molecule p62/SQSTM1 
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however, which is involved in cargo targeting to autophagosomes, did colocalize 
(Kleine et al., 2012). None of the domain modifications seemed to influence the 
overall cellular distribution of ARTD10 [Figure 13]. The G888W mutant however is 
the only construct resulting in extensive dot formation after 4 hours an outcome also 
seen in transient experiments. This may suggest, that catalytic activity is needed to 
antagonize accumulation of ARTD10 in those structures. 
 
 
Figure 13. Subcellular localization of ARTD10 and ARTD10 mutants in stable HeLa cells. 
The indicated cell lines were seeded on coverslips and protein expression was induced with 1 µg/ml doxycycline 
for 4 h with or without the addition of 20 nM Leptomycin B. Cells were fixed with PFA and ARTD10 was stained 
using the monoclonal antibody 5H11. Nuclei were stained using Hoechst 33342. 
 
5.1.2 ARTD10 influences cell growth in HeLa Flp-In T-Rex 
Initial characterization of the cell growth behavior was done using colony formation 
assays. 100 cells were seeded in 6-well dishes, the expression of the different 
proteins induced and the colonies were fixed and stained with methylene blue after 
11 days. Additional proteins could be introduced the day after seeding by transfection 
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of their expression vector. Figure 14A shows the outcome of a colony formation with 
the different HFT ARTD10 cells as well as control HFT without a transgene to control 
for doxycycline effects. Without induction the size of the single colonies varied slightly, 
but the amount of colonies was equal, an effect that was most likely due to different 
basal growth rates of the clones. Addition of doxycycline however completely 
abolished colony formation in the case of wt3, an outcome which is consistent with 
previous findings in transient colony formation assays (Schuchlautz, 2008). Cells 
overexpressing ARTD10 mutants did not show this effect, an indication that the 
integrity of the full-length protein is very important, as each mutation represents most 
likely a drastic impact on the proteins morphology or functionality. Unfortunately this 
complicated the research for the underlying factors leading to the diminished cell 
growth, as no domain’s implication can be ruled out. 
 
Although it is an easy method to obtain an overview on the overall cell growth rate, 
the experiments measure an end point, i.e. the final amount of cells. Further 
conclusions on the underlying cause, be it delayed or blocked cell cycle or even cell 
death, was not possible. 
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Figure 14. ARTD10 inhibits cell growth in HeLa Flp-In T-Rex cells. 
(A) Colony formation experiment using clones of the established HFT ARTD10 cell lines with Ø indicating control 
HFT cells. 100 cells were plated and grown with and without addition of 1 µg/ml doxycycline for 11 days and 
subsequently stained with methylene blue. The experiment was performed in duplicates. 
(B) Growth curves of different HFT ARTD10 cell constructs with Ø indicating control HFT cells. 10,000 cells were 
seeded, grown with and without doxycycline and counted over 5 days. 
(C) Growth curves of different wt3, GW4 and empty HFT cells. 30,000 cells were seeded, grown with and without 
doxycycline and counted over 5 days. The experiment was performed in a triplicate.  
 
The different colony size in uninduced samples could be an indication for a different 
overall growth rate of each cell line [Figure 14A]. To address this question cell 
proliferation of an exponentially growing culture was assessed as shown in Figure 
14B and C. The cells were seeded at a low density in 5 plates. The cells of individual 
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plates were counted at each time point using the CASY cell counter. For clarity 
control HFT as well as wt3 and GW4 are arranged together. As expected the cells 
show a slightly different growth rate even in the uninduced state, which could be 
explained by the use of single clones. Upon induction however only wt3 cells grew 
significantly slower [Figure 14]. In analogy to the findings above in the colony 
formation assays, mutated ARTD10 did not have this impact on the cells. The ΔNES, 
ΔUIM, Δ219-502 and ΔK proliferated at the same rate with or without doxycycline 
[Figure 14B]. Therefore those ARTD10 mutants were not used in further experiments 
and we concentrated on wt or GW cells.  
 
To further elucidate the nature of the inhibitory effect, especially if the prolonged and 
continuous expression of ARTD10 was needed, colony formation assays were 
performed with a time-restricted induction of ARTD10. In an initial experiment wt3 
and GW4 cells were treated with doxycycline for 24 or 48 hours followed by growth in 
normal medium. The plates and their quantification in Figure 15A showed a slight 
decrease in the number of colonies after 24 hours as well as even less colonies after 
expression of ARTD10 over two days, while the catalytic inactive ARTD10 showed 
no effect. Subsequent experiments extending the time of doxycycline application 
revealed that indeed at 2 days the maximum effect was achieved and prolonged 
ARTD10 expression from this point on did not further decrease colony number 
[Figure 15B].  An explanation for this non-linear effect could be a continuous 
apoptosis in a small number of cells throughout the experiments. On the other hand 
induction of the apoptotic effect only in the first 48 hours in a percentage of cells 
would result in a delayed onset off exponential cell growth and smaller, invisible 
colonies in colony formation assays. These two mechanisms could not be 
distinguished with the assays used. A third possibility would be that ARTD10 was 
required at a certain level within the cell and had to accumulate over time to trigger 
the inhibitory effect. As shown in Figure 12E the exogenous ARTD10 was detectable 
even with 10 ng/ml doxycycline. To determine the influence of the protein amount on 
the growth inhibiting effect, a dose response assay was performed using the colony 
formation assay. Dosages from 5 to 1000 ng/ml were applied to the HFT containing 
the wild-type form of ARDTD10 during the whole growth period. Quantification 
revealed that while 5 ng/ml were sufficient to reduce the colony number, the 
application of 5 times the amount of doxycycline lowered it to a minimum [Figure 
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15C]. Further increase of the antibiotic did not have an additional effect. Although the 
quantification of the colony formation assays resulted in high standard deviations, the 
tendency was the same in each experiment. To further elucidate the nature of 
ARTD10’s growth inhibiting effect one would have to combine time and amount of 
applied doxycycline. It would be interesting to see whether the combination of the 
minimal values, in this case 2 days and 25 ng/ml doxycycline, is still sufficient to 
induce the limited cell growth. 
 
 
Figure 15. Influence of time and concentration of doxycycline treatment on cell growth. 
(A) Colony formation (CF) experiment with wt3 and GW4 cells, in which either ARTD10 expression was 
uninduced or induced for 24 or 48 h. After 7 days the cells were stained with methylene blue (left panel). A 
quantification of the CF is shown on the right. 
(B) Quantification of an extended induction colony formation with wt3 cells. Again the cells were either uninduced 
or induced for the indicated times. After 8 days the cells were stained with methylene blue and quantified. The 
experiment was performed in duplicates. 
(C) Quantification of a colony formation experiment with wt3 cells induced with different amounts of doxycycline. 
The cells were grown for 8 days with the indicated antibiotic amount and subsequently stained with methylene 
blue and quantified. The experiment was performed in duplicates. 
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Taken together the results shown in Figure 14 and Figure 15 strongly suggested a 
negative effect of ARTD10 on cell growth in HFT cells. This effect was both reliant on 
strength as well as length of induction, with defined points of maximum efficiency. 
Regarding the nature of this negative effect the conducted experiments were not 
sufficient to make further conclusions. The elucidation of this issue will be addressed 
in the next chapter.  
 
5.1.3 ARTD10 induces apoptosis 
Throughout the preceding experiments the observation of HFT, expressing the wild-
type ARTD10, using an optical microscope revealed an increase in dead and non-
adherent cell. To elucidate whether the growth inhibitory effect described in the last 
chapter was due to dying cells and not inhibition of cell proliferation per se, the 
number of dead cells in the samples was quantified. Propidium iodide (PI) is a widely 
used chemical to distinguish viable from dead cells. It is a DNA intercalating as well 
as fluorescent substance that can be excited at a wavelength of 488 nm. It is 
excluded from viable cells, as it cannot penetrate cells with an intact cell membrane. 
When cell membrane integrity is lost during cell death, PI is taken up by the cells and 
intercalates into the DNA. PI containing cells are easily detectable by various 
methods, e.g. FACS analysis. Figure 16 shows two FACS histograms of wt3 and 
GW4 cells stained with PI after expression of ARTD10 for 3 days. The background 
level of dead cells in culture was at about 4 percent for both constructs, which was 
comparable to viability scores obtained with the CASY cell counter. Expression of 
ARTD10 led to an increase of dead cells to about 36%, whereas no increase in PI 
positive cells was measurable for GW4. 
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Figure 16. Overexpression of ARTD10 induces cell death. 
FACS analysis of dead cells after ARTD10 expression in wt3 and GW4 cells. The cells were grown for three days 
with or without doxycycline and afterwards stained with propidium iodide. The cells were counted and analyzed 
using FACS. 
 
The outcome of this experiment confirmed the initial observations made in cell culture 
using light microscopy. The effects seen in colony formation and proliferation assays 
seemed to be in large part due to the death of the cells. The analysis in Figure 16 
represents an end point analysis of cells that lost the integrity of the plasma 
membrane. However cells that died early in the experiment and disintegrated were 
not analyzed. Therefore these measurements could not be compared directly to 
those obtained in the colony formation and proliferation assay experiments. In 
addition the quantification of dead cells as measured here by FACS did not 
contribute to the understanding of why and how those cells died. In order to 
understand the functions ARTD10 might have had and how it led to cell death, it had 
to be distinguished what kind of death these cells undergo.  
 
The form of a cell’s death can be characterized by various biochemical features as 
described in chapter 4.2. A list of those features and methods of detection is provided 
in Table 2 for apoptosis. The apoptotic phenotype is very distinct and is characterized 
by membrane-blebbing and apoptotic bodies, which can also be observed by light 
microscopy. But as stated in chapter 4.2 with new forms of cell death intermediates 
emerging more and more it is more suitable to characterize those forms by 
experimental quantification of their biochemical features. 
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A method widely used for determination of apoptotic cells is annexin V staining of the 
cells (Vermes et al., 1995). Annexin V is a protein that Ca2+-dependently binds 
phosphatidylserine (PS), a phospholipid that is exposed on the outer cell membrane 
during early apoptosis [see chapter 4.2.2.1]. Using FACS a fluorescently labeled 
annexin V marks cells exposing PS. But as loss of membrane integrity leads to the 
diffusion and binding of annexin V to intracellular PS and subsequently to a false 
positive signal, the cells have to be counterstained with PI to exclude already dead 
cells. Control HFT cells as well as wt3 and GW4 were subjected to an annexin V 
assay to detect PS exposure. Following a three day induction of expression of 
ARTD10 or ARTD10-G888W the cells were trypsinized and stained with FITC 
labeled annexin V and PI before FACS analysis was carried out. The topoisomerase 
inhibitor etoposide, an agent known to induce apoptosis, was used as positive control. 
Figure 17A shows histograms of the annexin V signal measured by FACS with PI 
positive cells gated out. All three samples showed an increase in PS exposure 
following the etoposide treatment. Expression of wild-type ARTD10 also induced the 
translocation of PS to the outer membrane leaflet, though not as strong as the 
cytotoxic agent. Control cells and GW4 however were not affected by doxycycline 
addition. Compared to the positive control the actual shift was not that distinct, 
meaning that apparently not as much PS was exposed at the surface. The cytotoxic 
effect of etoposide seemed to cause a stronger apoptotic response within the cell. As 
the explicit pathways regarding PS exposure during apoptosis are not known 
conclusions on the cause cannot be made. 
 
To further ensure the form of cell death a second biochemical approach was used. 
The cleavage of the bona-fide PARP ARTD1 during apoptosis by caspase-3 
guarantees the shutdown of DNA repair (Lazebnik et al., 1994; Tewari et al., 1995). 
Processing of the 113 kD protein at D214 results in a 24 kD N-terminal and an 89 kD 
C-terminal part, which can be detected using fragment specific antibodies. A western 
blot of ARTD1 cleavage in wt3 compared to GW4 cells is shown in Figure 17B. In wt3 
cells consistent with the so far established time frame of cell death a weak signal for 
the 89 kD fragment at 24 h of ARTD10 induction could be seen [compare Figure 15 
and Figure 16]. With continuous expression over 48 h the signal increased. The 
catalytic inactive mutant of ARTD10 did not cause any cleavage of ARTD1 above 
background. In comparison to other apoptotic stimuli like UV [Figure 22 and Figure 
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23] the full length ARTD1 amount seemed not to be altered, an indication that 
apoptosis was induced only in a subset of cells, whereas others were still viable. This 
was consistent with the data seen in Figure 15 and Figure 16 where depending on 
the experimental setup, especially the time frame, the rate of dead cells ranged from 
30 to 70%. 
 
 
Figure 17. ARTD10 overexpression induces PS exposure and ARTD1 cleavage in HFT cells. 
(A) wt3, GW4 and control cells were treated with or without doxycycline for three days. In addition the cells were 
treated with 20 µM etoposide for 48 hours. The cells were then stained for annexin V and PI and analyzed by 
FACS. PI positive cells were gated out and histograms of the annexin-V-FITC intensity are shown. 
(B) wt3 and GW4 cells were induced with doxycycline for the indicated times and the cleavage of ARTD1 
analyzed by immunoblotting. The cleaved fragment of ARTD1 at 89 kD is indicated. Tubulin was detected as 
loading control. 
 
With the analysis of PS exposure and activation of caspases two methods described 
in Table 2, the results pointed towards apoptosis as underlying mechanism of cell 
death. A third method was used to confirm this interpretation. Cells undergoing 
programmed cell death loose their DNA and nuclear integrity. Nucleosomal 
fragmentation and DNA degradation contribute to the lower nucleic acid content 
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resulting in hypodiploid cells, which can be measured in FACS analysis (Telford et al., 
1991, 1992). During this assay cells were trypsinized and stained with Vybrant 
Dyecycle Violet stain, a DNA intercalating, fluorescent substance, which in contrast 
to PI is plasma membrane permeant. The molecule is taken up into the cell, binds 
DNA and can be subsequently used to quantify the DNA content in living cells. 
Histograms of the FACS analysis conducted after staining represent the cells cell 
cycle stages. A G0/G1 peak (2n DNA) is followed by a broader range of cells in 
S-phase containing variable amounts of DNA. The right side of the cell cycle diagram 
shows in an additional peak the G2/pre-mitotic cells with double the amount of DNA 
(4n DNA). Counted events outside this cell cycle area are cell aggregates, hyperploid 
cells or at lower intensity cell debris and hypodiploid cells. After exclusion of the cell 
debris by size the hypodiploid population, appearing in the so-called sub-G1 peak left 
from the G0/1 peak, can be quantified. Using this assay with wt3 and GW4 cells a 
normal cell cycle distribution with all three phases could be observed [Figure 18]. The 
impact of ARTD10 expression on those cells was monitored over 2 days. Whereas 
the GW4 cell cycle did not show any change during the experiment time frame, the 
wild-type samples showed a loss of viable cells and the appearance of the above-
mentioned sub-G1 peak with up to 20% of apoptotic cells.  
 
Figure 18. ARTD10 overexpression induces the formation of a sub-G1 peak. 
wt3 and GW4 cells were induced for ARTD10 expression for the indicated times. The DNA content was stained 
with Vybrant Dyecycle Violet stain and the cells were analyzed using FACS. Representative histograms are 
shown with percentages of cells in the sub-G1 peak. 
 
With the detection of the sub-G1 peak, indicating DNA breakdown, the cleavage of 
ARTD1 by caspases and the PS exposure, three independent biochemical methods 
confirmed hallmarks of apoptosis. Although more methods are available to verify 
Results & Discussion  46 
apoptosis further [Table 2], it can be stated that expression of ARTD10 induces 
apoptosis in HeLa cells, an outcome that is not visible with the catalytically inactive 
mutant.  
 
In a first approach to obtain insight into how ARTD10 induces apoptosis, colony 
formation assays were conducted after transfection of two anti-apoptotic BCL-2 
family members, namely BCL-2 as well as BCL-XL. To control their function, the 
proteins were overexpressed in HeLa cells, the intrinsic pathway was induced by 
addition of staurosporine and apoptosis was monitored subsequently by detection of 
ARTD1 cleavage [Figure 19B]. Especially BCL-XL was able reduce the cleavage of 
ARTD1 and was therefore used in a further colony formation experiment. BCL-XL as 
member of the BCL-2 family belongs to their pro-survival subgroup, which contain all 
four BH domains and function as antagonists to the BH1-3 proteins by binding to 
BAX/BAK and inhibition of their pore forming abilities (Cheng et al., 2001; Ruffolo and 
Shore, 2003; Strasser, 2005). BCL-XL is also able to inhibit apoptosis when 
BAX/BAK binding is impaired through mutations, potentially through the ability to bind 
tBID, BIM or BAD (Cheng et al., 1996; Cheng et al., 2001). Use of BCL-XL resulted in 
an increase of colony numbers around 20% when it was co-expressed with HA-
tagged ARTD10 in HeLa cells [Figure 19B]. To transfer these results to the HFT cells 
and at the same time facilitate the quantification, wt3 cells were seeded, transfected 
with BCL-XL or the correspondent backbone vector and let grown for 5 days with or 
without induction of ARTD10 expression. Finally cells were counted using the CASY 
cell counter. Expression of BCL-XL in those cells led to an increase of more than 2 
times the cell number. This effect could also be observed when ARTD10 expression 
was induced [Figure 19C]. To better compare the reduction of cell number the results 
for the samples without BCL-XL were set to 100 % and plotted accordingly [Figure 
19C, right panel]. The population of surviving cells was with 33 % in the sample 
expressing BCL-XL 10 % higher than in the sample lacking the anti-apoptotic protein. 
Although the effects were rather small, cell growth was recovered to a certain extend 
when BCL-XL was overexpressed. This suggests at least in part the involvement of 
the mitochondrial pathway of apoptosis. Although no external stimuli were applied to 
the HFT cells it is still possible that ARTD10 engages the extrinsic apoptosis pathway 
downstream of those receptors, circumventing the intrinsic pathway. Additional 
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experiments with other members of the BCL-2 or IAP family or inhibitory proteins like 
FLICE would facilitate further interpretations. 
 
 
Figure 19. BCL-XL partially rescues the apoptotic effect of ARTD10. 
(A) HeLa cells were transfected with plasmids expressing BCL-2 or BCL-XL and apoptosis was induced by 
addition of staurosporine for 3 hours. ARTD1 cleavage was monitored using SDS-PAGE and western blotting. 
(B) Colony formation assay showing HeLa cells transfected either with pBabePuro and pEVRF0-HA-ARTD10 
alone or in combination with pMSCV-BclXL-GZ, a mammalian expression vector for the anti-apoptotic protein 
BCL-XL. Cells without transfection (empty) and cells transfected with a p27 expression plasmid were used as 
controls. The cells were stained with methylene blue and subsequently quantified (right panel). 
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(C) HFT wt3 cells were transfected with either pH2B-YFP or pMSCV-BclXL-GZ with and without the induction of 
ARTD10 expression. After 4 days the cells were counted (left panel). To focus on the BCL-XL effect cell numbers 
were calculated in relation to the uninduced sample (right panel). The experiment was performed in triplicates. 
 
The question of how ARTD10 induces apoptosis is still in need of further 
investigations, but several findings help to link ARTD10 to apoptotic events observed 
in other fields of molecular research. An interaction that was found recently describes 
the partial co-localization of ARTD10 with p62/SQSTM1, an adapter protein that links 
poly-ubiquitinated proteins to autophagosomes (Johansen and Lamark, 2011; Kleine 
et al., 2012). Its interaction with LC3-II and its UBA domain are essential for this 
function, the latter of which is also required for the mentioned ARTD10 co-localization 
(Kirkin et al., 2009). This connection to autophagy has still to be elucidated and 
possible implications of ARTD10 on autophagy or whether the interaction is due to 
turnover of ARTD10 is not yet known. However p62 apart from its function in 
autophagy was initially characterized as molecule involved in signaling processes of 
cell survival and apoptosis through its ability to oligomerize and bind poly-ubiquitin 
chains (Moscat and Diaz-Meco, 2009). In inflammatory pathways mediated through 
ligands like IL-1β and TNF-α p62 is a critical factor in propagating the NF-κB signal. 
Binding and clustering of RIP-1 and TRAF6 in p62-speckles facilitate the propagation 
(Sanz et al., 2000; Sanz et al., 1999). During IL-1β signaling p62 positively influences 
the auto-ubiquitination of TRAF6 and thereby the following downstream events 
[Figure 20] (Sanz et al., 2000). Recently established data revealed that ARTD10 is 
also linked to NF-κB signaling. Overexpression of the protein leads to a decrease in 
NEMO ubiquitination (a TRAF6 substrate), blocked p65 translocation to the nucleus 
and repressed NF-κB target gene expression (Verheugd et al. submitted). 
Co-immunoprecipitation experiments in addition show a weak interaction with p62, 
but where performed without any stimuli to the cells (Kleine et al., 2012). At this point 
it is worth mentioning that p62 was not confirmed as target of ARTD10. Taken 
together the data could explain the apoptotic effect in HeLa cells, as the NF-κB 
pathway regulates proliferation and apoptosis and is upregulated in many tumors 
(Rayet and Gelinas, 1999). A shutdown of any residual NF-κB activity in those cells 
through ARTD10, either direct through inhibition of NEMO ubiquitination or through a 
possible influence on p62, enhanced by the local enrichment of interaction in 
p62/ARTD10 bodies, could possibly result in the observed cell death.  
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p62 is also connected to TRAIL, an apoptosis inducing ligand, that stimulates the 
extrinsic pathway through formation of the DISC involving the initiator caspase 8 
(Wilson et al., 2009). Upon ligand binding the caspase activation is amplified through 
p62 in a mechanism similar to the one described above for NF-κB [Figure 20]. The 
E3 ligase CUL3 poly-ubiquitinates the recruited caspase-8, p62 binds through its 
UBA domain and aggregates the caspase in the former mentioned speckles, leading 
to enhanced activation (Jin et al., 2009; Moscat and Diaz-Meco, 2009). Although in 
the stable HeLa cells no external death stimulus is applied and caspase-8 might not 
be ubiquitinated, the p62-speckles as signaling hubs for caspase-induction are of 
interest and provide another link between ARTD10 and apoptosis.  
TNF signaling in contrast to TRAIL is capable of inducing an anti-apoptotic, 
inflammatory response as well as mediating cell death through a secondary complex 
(Muppidi et al., 2004). Upon stimulation a complex I is formed mediating the NF-κB 
signal through the IKK complex (Zhang et al., 2000). This complex consists of the 
receptor itself, TRADD, RIP-1 and TRAF2. Those proteins can also dissociate 
together from the receptor. The death domain (DD) of TRADD, now free from TNFR 
DD interaction, can recruit FADD and subsequently caspase-8 building the so-called 
complex II, which facilitates the apoptotic response. Under normal circumstances the 
protein FLIP, which is expressed in response to the NF-κB pathway, blocks the pro-
apoptotic function of complex II. Failed induction of this pathway by complex I 
therefore would lead to sustained complex II activity and finally to apoptosis and 
clearing of the cell from the system (Micheau and Tschopp, 2003). Although no 
external TNF-α stimulation occurs in the HFT cells, the inhibiting effect of ARTD10 on 
NF-κB could be enough to push residual TNF-α signaling in cell culture towards 
complex II activity in the stable cell lines explaining the apoptosis. All of these models 
could be investigated using the mentioned external apoptotic stimuli like TRAIL or 
TNF-α in combination with ARTD10 overexpression or knockdown to evaluate a 
possible increased or diminished apoptosis induction by those ligands. To exclude 
the toxic effect of ARTD10 itself these experiments should be conducted in different 
cell lines. 
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Figure 20. Implication of p62 in TRAIL and NF- κB signaling [adapted from (Moscat and Diaz-Meco, 2009)]. 
K63-linked poly-ubiquitination of core components of the TRAIL and NF-κB pathways allows the binding of p62. 
The adaptor protein aggregates the essential signaling molecules in hubs and potentiates interaction and the 
resulting signal. 
 
Another connection between ARTD10 and p62 is based on the observation, that p62 
is essential in RAS mediated tumor transformation again due to influence on NF-κB. 
The activation of the pro-survival NF-κB pathway through RAS is important during 
RAS-mediated transformation because it counteracts RAS-induced p53-independent 
cell death (Mayo et al., 1997). p62 in this pathway seems to be the link between RAS 
and IKK activation and subsequent downstream events, as loss of p62 reduces 
NF-κB activation and transformation (Duran et al., 2008). The inhibition of oncogenic 
RAS-mediated transformation was also observed in a setup where ARTD10 was 
overexpressed in rat embryonic fibroblasts (Yu et al., 2005). The decreased 
transformation is not dependent on ARTD10 activity but on its localization, as the 
ΔNES mutant of ARTD10 abrogates this effect. An alternative mechanism apart from 
catalytic activity, perhaps through the interaction shown in co-immunoprecipitation 
experiments, seems therefore to be likely (Kleine et al., 2012). A direct inhibition of its 
function by modification can be excluded, as p62 could not be confirmed as ARTD10 
substrate. These data reveal another interesting connection between ARTD10 and 
p62 in an NF-κB pathway background and further strengthen the idea that ARTD10 
regulates this signaling process resulting in decreased cell survival. 
 
In contrast to p62, which is not modified by ARTD10, several proteins involved in 
mitosis regulation were identified as strong hits in our substrate screen (Feijs et al. 
submitted). This is especially interesting as the so-called mitotic catastrophe is an 
often-observed outcome of deregulated or failed mitosis, wherein the cell finally 
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succumbs to DNA damage or checkpoint errors. The precise definition of this 
process is highly discussed, but several publications link mitotic catastrophe to 
apoptosis, as it can show several hallmarks of the latter (Castedo et al., 2004; 
Kroemer et al., 2009; Vakifahmetoglu et al., 2008). As mentioned above ARTD10 
modified different kinases that control mitosis in a substrate array screen, among 
them PLK1, Aurora-A and NEK6, all three of which are known to be involved in 
processes like mitotic spindle establishment or centrosome regulation. (Loffler et al., 
2006; Ma and Poon, 2011; O'Regan and Fry, 2009). Deregulation of these kinases is 
fatal as reported by several groups and could provide a link back to ARTD10 induced 
apoptosis. Overexpressed dominant negative PLK-1 induces mitotic catastrophe in 
HeLa cells and apoptosis in several other cancer cell lines (Cogswell et al., 2000; 
Mundt et al., 1997). Similar observations were made for the NIMA related kinase 
NEK6, where depletion of the protein or the overexpression of a kinase-dead version 
triggers an apoptotic response in epithelial cell lines, among them HeLa (Yin et al., 
2003). A model wherein apoptosis is induced by ARTD10 through a disturbed mitosis 
would fit to the observation that the onset of apoptosis in the HFT cells is rather late 
after approximately 24 hours. In addition errors during chromosome segregation and 
subsequent aneuploidy would only result in the death of particular cells and could 
explain remaining cells after several days of ARTD10 induction (Castedo et al., 2004).  
 
In conclusion many recent findings connect ARTD10 in several ways to apoptosis 
inducing pathways, but still the actual point of action in one of those has to be 
elucidated.  
 
 
5.2 ARTD10 is substrate of caspases 
5.2.1 ARTD10 is cleaved by caspases during apoptosis 
ARTD10 as shown in the last chapter induced apoptosis and with it the activation of 
caspases as seen in the ARTD1 western blot in Figure 17B. The processing of 
hundreds of substrates by caspases is the key to the process of programmed cell 
death [4.2.2.1 Caspases](Taylor et al., 2008; Timmer and Salvesen, 2007). During 
time course experiments with the HFT ARTD10 cells western blot analysis of the 
protein revealed an additional band at around 50 kD, which was only visible in the 
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cells expressing wild-type ARTD10 [Figure 21]. With the knowledge that ARTD10 
induced apoptosis it became obvious to ask, whether the appearance of the protein 
band was dependent on this process and if it was really a fragment of ARTD10 or 
rather an artifact of the antibody. In addition the overexpression in HFT resulted in a 
variety of smaller fragments during western blot analysis that could be due to 
different transcriptional start sites or degradation. Those possibilities could be 
excluded for the 50 kD band, as the catalytically inactive mutant did not show this 
and a stabilization of the protein through one amino acid change seemed unlikely. 
 
 
Figure 21. ARTD10 induction leads to fragment appearance. 
ARTD10 expression was monitored in wt3 and GW4 cells in response to doxycycline. Expression of ARTD10 was 
induced for the indicated times and the samples were analyzed by immunoblotting using the monoclonal 5H11 
antibody. Tubulin was detected to ensure equal loading. 
 
To link the fragmentation to apoptosis HFT cells expressing the wild-type form of 
ARTD10 were irradiated with UV light, which triggered the internal death program 
through massive DNA damage. Application of 20 mJ/cm2 at 254 nm was sufficient to 
induce apoptosis in the HFT cells as monitored by ARTD1 cleavage, which appeared 
already 2 hours after the stimulus. The same dynamic could be seen in the case of 
the ARTD10 fragment [Figure 22a, left panel]. Using different mono- and polyclonal 
antibodies that recognize different epitopes [see Figure 3] the possibility of an 
antibody-related artifact could be ruled out. Recognition by the rat monoclonal 
antibody 5H11 suggested that it was an N-terminal fragment. Moreover the 
polyclonal rabbit serum 890-6, raised against amino acids 1-907, detected a second 
signal increasing over time at around 90 kD, which was not recognized by 5H11 
[Figure 22A, right panel]. This suggested that it represented a rather C-terminal part 
of ARTD10 downstream of the 5H11 binding site. To verify this observation an 
antibody against the last 17 amino acids of ARTD10 (C-17) was used [Figure 22B]. A 
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protein species at the estimated size became apparent in parallel to the smaller 
N-terminal fragment. With the evidence of N-terminal and C-terminal protein 
fragments detected upon apoptosis induction, which added up to the length of the full 
protein, a cleavage of ARTD10 into two parts became likely. The cleavage at the 
same time as ARTD1 suggested that ARTD10 is a target of executioner caspases as 
ARTD1 is cleaved by caspase-3 and -7 (Boucher et al., 2012; Lazebnik et al., 1994).  
 
 
Figure 22. ARTD10 fragment appearance is consistent with apoptosis. 
(A) wt3 cells with induced ARTD10 expression (16 h) were treated with UV (20 mJ/cm2, 254 nm) for the indicated 
times. The cells were subjected to immunoblotting and ARTD10 was analyzed with the monoclonal antibody 5H11 
as well as the polyclonal antibodies E09 and 890-6 (see Figure 3). The appearing of N- as well as C-terminal 
bands are indicated. Detection of ARTD1 was used to monitor the induction of apoptosis, whereas tubulin served 
as loading control. 
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(B) Immunoblot with samples like in (A) using a C-terminal antibody (C-17). Tubulin was detected as loading 
control. 
(C) HeLa cells transfected with HA-ARTD10 as well as induced wt3 cells were subjected to different apoptotic 
stimuli (ø, no treatment; UV, 100 mJ/cm2 at 254 nm; ETO, 30 µM etoposide; STS 0,5 µM staurosporine) 6 hours 
prior to lysis. After immunoblotting the N- (5H11) as well as the C-terminal (3H5) fragment of ARTD10 were 
detected using the respective antibodies. ARTD1 cleavage was detected to ensure induction of apoptosis. 
GAPDH served as loading control. 
 
To further strengthen the idea of an apoptosis dependent process additional stimuli 
were used to induce the death of the cell. Etoposide, the topoisomerase inhibitor 
already used in Figure 17A as positive control, as well as staurosporine, a broadband 
kinase inhibitor known to trigger the intrinsic self-destruction program, were used 
(Belmokhtar et al., 2001; Karpinich et al., 2002). Upon application to induced wt3 
cells as well as transiently transfected HeLa cells the fragments at 50 and 90 kD 
appeared with staurosporine treatment similar to the findings in response to UV. 
Etoposide on the other hand failed to induce efficient ARTD10 cleavage [Figure 22C]. 
As ARTD1 analysis also did not show any cleavage in the case of etoposide, the 
induction of apoptotis did not seem to work in the first place.  
 
Although the likelihood of an antibody caused artifact was limited due to different 
antibodies, there was still the possibility the bands being an overexpression 
phenomenon. To address this concern endogenous protein had to be monitored. 
While the HFT cells represented a good model for studies with exogenous ARTD10, 
the endogenous level was too low to be detected in a straight western blot. The 
monocytic leukemia cell line THP-1 shows higher levels of ARTD10 and was used for 
further characterization of its fragmentation (Tsuchiya et al., 1980). As those cells 
grow in suspension apoptosis was induced with staurosporine and ARTD10 
fragments were monitored over 8 hours using western blot analysis [Figure 23A]. 
Consistent with the previous overexpression studies 4 hours after the apoptotic 
stimulus ARTD1 processing as well as fragmentation of ARTD10 could be observed. 
In contrast to the exogenous protein, which seemed to be resynthesized very rapidly, 
the amount of full length ARTD10 decreased with the appearance of the fragments. 
The fragments themselves were stable during the time course of the experiment. 
Similar to Figure 22A/B the protein fragments stayed visible up to the last time point 
at 8 hours. The drawbacks of the polyclonal 891-6 serum were numerous 
background bands and a weak signal for the bigger fragment and therefore 
monoclonal antibodies with epitopes in the N- (5H11) and C-terminus (3H5) were 
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used [Figure 23B]. As equal irradiation with UV light was not applicable to 
suspension cells, etoposide as another stimulus was used. Both treatments were 
able to induce the same ARTD10 fragmentation with an N- and C-terminal fragment 
[Figure 23B] and seemed to be sufficient to induce apoptosis in THP-1 cells. 
 
 
Figure 23. Induction of apoptosis leads to ARTD10 fragmentation in THP-1. 
(A) Apoptosis was induced in THP-1 cells by application of staurosporine (1 µM) for the indicated times. 
Endogenous ARTD10 was analyzed by immunoblotting using the polyclonal 891-6 antibody.  ARTD1 was 
detected to monitor induction of apoptosis, whereas α-tubulin detection served as loading control. The N- as well 
as the C-terminal ARTD10 fragment are indicated. 
(B) In addition to staurosporine another set of cells was treated with 30 µM etoposide for 3 h. ARTD10 was 
analyzed after immunoblotting where it was detected by an N- (5H11) and C-terminal (3H5) monoclonal antibody. 
The appearing fragments are indicated. The detection of α-tubulin served as loading control.  
 
The results of the experiments shown in Figure 22 and Figure 23, i.e. the decrease of 
endogenous ARTD10 and the fact that two fragments complementary in size 
appeared simultaneously with ARTD1 cleavage, pointed towards proteolytic cleavage 
during apoptosis. To validate that ARTD10 is processed by caspases, the proteolytic 
key factors during apoptosis, the pan-caspase inhibitor Z-VAD-fmk was used to 
inactivate those enzymes [Figure 24]. Z-VAD-fmk is a cell permeant peptide inhibitor 
that inside the cell irreversibly binds to the catalytic site of caspases rendering them 
inactive and thereby preventing apoptosis (Zhu et al., 1995). HeLa cells transiently 
transfected with HA-tagged ARTD10 as well as induced wt3 cells were irradiated with 
UV to induce apoptosis with and without the simultaneous application of the inhibitor 
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to the medium. The cells were harvested and analyzed using SDS-PAGE and 
western blotting.  
 
 
Figure 24. Fragmentation of ARTD10 is blocked by the caspase inhibitor ZVAD-fmk. 
(A) Apoptosis was induced in HeLa cells transfected with pEVRF0-HA-ARTD10 using UV (20 mJ/cm2 at 254 nm) 
4 h prior to lysis. Caspases were blocked using the inhibitor Z-VAD-fmk (20 µM). ARTD10 was detected using the 
polyclonal E09 antibody. ARTD1 detection served as monitor for apoptosis induction and α-tubulin detection was 
used as loading control.  
(B) HFT wt3 cell were treated like described in panel (A). In addition to the N-terminal fragment, the bigger 
C-terminal part was detected using the 3H5 antibody. 
 
ARTD1 cleavage as positive control for the induction of apoptosis could be observed 
in both cases [Figure 24A/B]. As expected both fragments, as detected by N- (E09) 
and C-terminal (3H5) antibodies, appeared in parallel to ARTD1 processing [Figure 
24B]. Application of Z-VAD-fmk to the cells abolished ARTD1 fragmentation in 
normal HeLa as well as HFT cells [Figure 24A/B]. At the same time both ARTD10 
fragments vanished, leading to the assumption that indeed ARDT10 was targeted by 
caspases during the apoptotic process. The emerging question as to which caspase 
was responsible will be addressed in the next chapter. 
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5.2.2 ARTD10 is target of caspase 1,6 and 8 in vitro 
ARTD10 was cleaved during apoptosis, a process in which the initiator as well as 
executioner caspases are fundamentally important (Fan et al., 2005). Although the 
third group of inflammatory caspases [Table 3] is not involved in apoptotic cell death, 
all caspases were purchased as purified proteins in order to conduct in vitro caspase 
cleavage assays. In a first assay in vitro purified TAP-tagged ARTD10-G888W was 
used as substrate and incubated in the suitable caspase reaction buffer with each 
caspase. The samples were separated by SDS-PAGE and subsequently blotted to 
detect the N-terminal ARTD10 fragment using the monoclonal antibody 5H11. 
Caspases 1, 6, 7 and 8 seemed to be able to cut, but only caspases 1, 6 and 8 
showed a fragment of the expected size at around 50 kD comparable to the in vivo 
recognized fragment [Figure 25A]. Caspase-1 produced an additional piece at 70 kD, 
whereas the incubation with caspase-7 resulted only in one large fragment at 110 kD. 
It was not possible to detect the corresponding C-terminal fragments with the 
antibodies available. Further degradation or instability could be the cause of this. In 
addition the potential of the in vitro purified caspases to cleave a substrate was 
dependent on its origin. Immunoprecipitated endogenous ARTD10 from THP-1 was 
only cut by caspase-1 at a second site or by caspase-6 [Figure 26]. This could be 
due to in vivo modifications or different folding of ARTD10, which prevented the 
cleavage.  
 
The conducted experiments however showed that full length ARDT10 was in vitro 
targeted by caspases 1, 6 and 8 most likely at the same site, whereas caspase-7 
only and caspase-1 additionally cleaved at a secondary site. 
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Figure 25. In vitro caspase assay with purified TAP-ARTD10-GW and GST-ARTD10 fragments. 
(A) In vitro caspase assay with TAP-tagged ARTD10-G888W and recombinant caspases. The assay was stopped 
with addition of sample buffer and subjected to gel electrophoresis and immunoblotting with the N-terminal 5H11 
antibody. The in vivo observed fragment is indicated. 
(B) In vitro caspase assay with a GST tagged recombinant fragment of ARTD10 containing the amino acids 206-
459 and recombinant caspases. The assay was stopped using sample buffer and proteins were separated by 
SDS-PAGE and stained with coomassie brilliant blue. Arrows indicate cleaved proteins. 
 
As only the 50 kD fragment could be observed in vivo, the focus turned to finding this 
specific restriction site. The size of the fragment and recognition by the 5H11 
antibody, which recognized an epitope between amino acids 259 and 408, led to the 
conclusion that the cleavage occurred C-terminal of amino acid 400. To confirm this 
a GST-purified ARTD10 fragment of amino acid 206-459 was used in a caspase 
assay. Control samples without GST-protein were run to ensure that bands resulted 
from cleavage, as the protein background in the acquired caspases was high. The 
experiment showed that indeed incubation with caspases 1, 6 and 8 resulted in a 
truncated form of the protein, which was around 5-7 kD smaller and predominantly 
produced by caspase-6 [Figure 25B]. This was in line with the caspase assay 
performed with TAP-purified protein. The fact that Caspase-7 did not process the 
GST-fragment was expected, as the larger fragment suggested a cleavage site not 
present within the used protein. The same was true for the larger fragment observed 
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using caspase-1. Nonetheless the experiment helped to narrow down the major 
cleavage site to a region around amino acid position 420. 
 
Until now ARTD10 was tagged, overexpressed and purified from E. coli and HEK293 
cells. In follow up experiments endogenous protein was immunoprecipitated from 
THP-1 cells and subsequently used in caspase assays to obtain the protein in its 
most natural condition. In contrast to the experiments before incubation of the protein 
with caspase-1 only resulted in the larger 70 kD fragment whereas the 50 kD 
fragment could only be produced using caspase-6. None of the other utilized 
caspases resulted in cleavage of immunoprecipitated ARTD10 [Figure 26]. An 
explanation could be conformational changes of the protein due to longer purification 
times, different buffers or storage, when one compares the immunoprecipitation with 
TAP-purification protocols. An unnatural folding could prevent recognition and 
cleavage. Although a possibility, the repeated use of TAP-purified protein in PARP 
assays showed that ARTD10 is active and the TAP-purification as a method used to 
identify interaction partners suggests a natural confirmation within these conditions. 
Phosphorylation as posttranslational modification could also block cleavage site 
recognition in ARTD10 like it is the case for BID or other caspase substrates 
(Desagher et al., 2001; Duncan et al., 2011). Such modifications could be lost while 
preparing and storing the sample rendering the cleavage site accessible for less 
active or less specific caspases. 
 
Figure 26. In vitro caspase assay with immunoprecipitated ARTD10 from THP-1. 
THP-1 cells were used to immunoprecipitate endogenous ARTD10, which was subjected to a caspase assay with 
recombinant caspases. After separation in SDS-PAGE and western blotting, ARTD10 and its fragments were 
detected using the 5H11 antibody.  
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Regarding the efficiency of cleavage during these experiments one has to bear in 
mind that the purchased caspases are not very pure and concentration variations are 
very likely. In addition substrate priorities and assay conditions play a role in caspase 
activity. To at least ensure that the specific tubes contained the advertised caspases 
4 of them were subjected to SDS-PAGE and western blotting and detected with 
specific antibodies. All antibodies recognize either the p20 or p10 subunit of the 
active caspase and all showed a signal with their respective target [Figure 27]. As 
there is no information by the supplying company on the constructs and eventual 
tags to purify the caspases further statements on the quality cannot be made. 
 
 
Figure 27. Immunoblot to control recombinant caspases. 
Recombinant caspases 1, 3, 6 and 8 were run in SDS-PAGE and blotted before detection with specific antibodies. 
Location of epitopes: 06-503: p20-subunit; SC-7148: p20-subunit; CS#9762: p15-subunit; SC-7890: p18-subunit. 
 
Although it needs further testing, especially in cells using knockouts or specific 
inhibitors of single caspases, caspase-6 seemed to be a promising candidate for the 
apoptotic processing of ARTD10. As there are concerns using inhibitors to 
discriminate between caspases due to low specificity, it is good that small molecule 
inhibitors are emerging which will be more suitable to the task (Chu et al., 2009; 
McStay et al., 2008). Caspase-6 was identified as ced-3 related protein MCH-2 and 
later classified as executioner caspase, which is responsible for the cleavage of 
nuclear lamins (Fernandes-Alnemri et al., 1995; Orth et al., 1996). Similar to 
caspase-3 and -7 during activation the short pro-domain as well as the linker domain 
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are separated through cleavage at three different sites from the p20 and p10 
subunits, which form the active caspase. In contrast to the other effector caspases 
caspase-6 is also able to auto-activate, a unique ability, the function of which is still 
unclear (Klaiman et al., 2009; Wang et al., 2010). Apart from lamins more than 60 
proteins have been reported over time to be target of caspase-6 (Graham et al., 
2011). Among those are structural proteins like alpha-tubulin, NuMa or lamin A, 
signaling proteins, transcription factors like NF-κB (p65) as well as the bona-fide 
executioner targets like ARTD1 (Hirata et al., 1998; Orth et al., 1996). The cleavage 
results in the typical apoptotic phenotype like breakdown of the cytoskeleton and 
nuclear matrix, shutdown of DNA repair and inhibition of anti-apoptotic signaling 
(Levkau et al., 1999). Interestingly caspase-6 also processes proteins of the 
autophagy machinery like ATG3 and ATG6 as well as p62, the autophagic adapter 
protein, which was recently shown to co-localize with ARTD10 in dynamic bodies 
(Kleine et al., 2012; Norman et al., 2010). Given a possible implication of ARTD10 in 
the autophagy process, its cleavage together with other key players in the autophagic 
process by the same caspase seems probable. The same is true for ARTD10 and 
the NF-κB pathway where a link is also provided by p62 as discussed earlier [see 
5.1.3]. 
 
The knowledge on caspase-6 has extended over the last decade, especially its 
implication in neuronal development and associated neurodegenerative diseases. 
During development of the nervous system inappropriate axons and redundant 
neurons are eliminated (Buss et al., 2006; Luo and O'Leary, 2005). Whereas 
caspase-3 is mainly responsible for disassembly of the neuronal body, caspase-6 
was shown to be the mediator of axon degeneration, a process that shows hallmarks 
of apoptosis like membrane blebbing and fragmentation (Graham et al., 2011; 
Nikolaev et al., 2009). This essential role in neurons also ties caspase-6 to 
neurodegeneration in Alzheimer’s, Huntington’s and Parkinson’s syndrome (Graham 
et al., 2011). Relevant proteins in those diseases like htt and TAU are caspase-6 
substrates and high expression and activation of the protease can be seen in 
affected tissues (de Calignon et al., 2010; Graham et al., 2010; Graham et al., 2011). 
Low amounts of ARTD10 mRNA were detected in the brain in a tissues screen using 
northern blotting (Yu et al., 2005). But especially this could render such tissues 
susceptible to elevated ARTD10 levels, as HeLa cells and the HFT cells used 
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throughout our experiments also showed no detectable endogenous protein in a 
western blot. These small amounts of ARTD10 are nonetheless essential for the cells, 
as knockdown of ARTD10 also reduces colony formation (Feijs, 2009). Processing of 
ARTD10 by caspase-6 in neuronal tissues could hint towards the importance of 
ARTD10 homeostasis in healthy cells and link ARTD10 to processes not necessarily 
involved in apoptosis.  
 
 
5.2.3  Definition of the caspase-6 cleavage site 
Experiments using in vitro caspase assays and antibodies recognizing different 
epitopes of ARTD10 located the in vivo caspase cleavage site to a position around 
amino acid 420 [5.2.2]. As caspases prefer an aspartate at position P1 [see 4.2.2.1] 
the sequence of ARTD10 was examined for potential restriction sites. Only a single 
aspartate at position 406 is present in ARTD10-(263-464). Hydrolysis at D406 would 
be consistent with the observed size of the fragments in apoptotic cells and the 
products both seen with full length and the GST-tagged part of ARTD10 [Figure 25]. 
Although caspases are reported to also cleave after glutamates, the majority prefers 
an aspartate at position P1 (Krippner-Heidenreich et al., 2001; Stennicke et al., 2000). 
The confirmation of the site D406 was approached by site directed mutagenesis of this 
residue to a glycine, which is known to abolish caspase-mediated processing 
(Bischof et al., 2001). HeLa cells were transiently transfected with HA-ARTD10 and 
HA-ARTD10-D406G and subsequently apoptosis was induced with UV irradiation or 
staurosporine. Z-VAD-fmk was used to demonstrate the caspase dependence. The 
cells were lysed and analyzed by SDS-PAGE and western blotting using a tubulin 
antibody as loading control and an ARTD1 antibody to indicate the induction of the 
caspase cascade [Figure 28]. As expected staurosporine [middle panel] as well as 
UV treatment [right panel] resulted in the appearance of the N-terminal ARTD10 
fragment in cells containing HA-ARTD10, which was abolished when caspases were 
inhibited by Z-VAD-fmk. Processing of ARTD1 was not inhibited to the same extend, 
but a clear reduction was visible. In the case of the mutated ARTD10 no cleavage 
band could be observed with either of the apoptotic stimuli, leading to the conclusion 
that amino acid D406 is indeed the in vivo target site of caspases. 
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Figure 28. In vivo test of suspected caspase restriction site at D406. 
HeLa cells expressing HA-ARTD10 or HA-ARDT10-D406G or control cells were treated with either staurosporine 
(1 µM) or UV (20 mJ/cm2 at 254 nm) to induce apoptosis or left untreated. In addition cells were incubated or not 
with Z-VAD. ARTD10 expression was analyzed with the 5H11 monoclonal antibody. Apoptosis induction was 
monitored using an ARTD1 antibody and α-tubulin was detected as loading control. 
 
Experiments in 5.2.2 showed that the caspases cleaving ARTD10 were somehow 
connected to the source of the protein. TAP-tagged exogenous protein was targeted 
by caspases 1, 6, 7 and 8, whereas immunoprecipitated ARTD10 was only cleaved 
by caspase-1 and -6. In addition the second fragment seen for caspase-1 in Figure 
25A also did not appear. To clarify the type of involved caspase the new mutant 
D406G was now tested in an in vitro caspase assay with immunoprecipitated HA-
tagged ARTD10. As TAP-tagged ARTD10 was produced in HEK293 cells those were 
additionally used to express the protein and see if the sensitivity to specific caspases 
was dependent on the cell line. The wild-type protein as well as the D406G mutant 
were immunoprecipitated with an HA-tag antibody (3F10) and subsequently used in 
caspase assays with caspases 1, 6, 7 and 8. The protein and fragments thereof 
where detected by western blot analysis using the N-terminal antibody 5H11. The 
observations confirmed those seen with immunoprecipitated endogenous ARTD10 in 
Figure 26. Regardless whether the proteins were obtained from HeLa or HEK293 
cells, only caspase-6 caused the 50 kD fragment seen in vivo, whereas caspase-1 
showed furthermore the band at 70 kD [Figure 29, left panels]. No processing of 
ARTD10 could be observed with either caspase-7 or -8. The use of the ARTD10-
D406G mutant abolished the cleavage by caspase-6 whereas the fragment produced 
by caspase-1 was still present [Figure 29, right panels]. Signals seen with caspase-7 
and -8 and ARTD10 immunoprecipitated from HeLa cells were probably background, 
as they do not appear in any of the other blots [Figure 29, upper right panel]. Taken 
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together one can conclude that in vitro caspase-6 is the main responsible caspase 
for cleavage at position D406, the site also targeted in exogenous ARTD10 upon 
induction of apoptosis. Caspase-1 however processed ARTD10 at a different site in 
vitro, an activity that has yet to be shown in cells. 
 
 
Figure 29. In vitro caspase assay with ARTD10 and ARTD10-D406G from HEK293 and HeLa. 
HA-ARTD10 and HA-ARTD10-D406G were immunoprecipitated from lysates of transiently transfected HEK293 
and HeLa cells. The immunoprecipitated proteins were subjected to an in vitro caspase assay with the indicated 
caspases and subsequently analyzed by western blotting using the N-terminal 5H11 antibody. The N-terminal 
fragment produced by caspase-6 is indicated. 
 
The full cleavage site from P4 to P2’ is ‘I A M D406 / S P’ for the caspase-6 site. As 
stated before the serine following the aspartate could be a point of regulation 
regarding recognition and cleavage. Several targets of caspases like BID, Max, or 
PTEN are phosphorylated within their cleavage site, influencing their processing 
(Desagher et al., 2001; Krippner-Heidenreich et al., 2001; Torres et al., 2003). The 
protein kinase CK2 is responsible for those phosphorylations and Duncan et al. took 
this as opportunity to summarize the implications of the overlap of kinase consensus 
sites with known caspase cleavage sites (Duncan et al., 2010). This kind of cleavage 
control could also be the case for ARTD10. The serine/proline combination is 
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common in motifs of kinases and among those are for example ERK2 and CDK1/2 
(Duncan et al., 2010; Schweigreiter et al., 2007). The latter was also reported to 
phosphorylate ARTD10 at T101, a modification that was connected to altered 
localization in the same study (Chou et al., 2006). Modification of serine 407 in 
ARTD10 and an inhibition of cleavage would add another level of regulation to 
ARTD10. Phosphorylation by a MAP kinase or a CDK would link ARTD10 cleavage 
control to the cells environment and the cell cycle. A substrate screen for ARTD10 
revealed that many of its targets are kinases, which adds the possibility for mutual 
regulation (Feijs et al. submitted). This could be similar to the interplay between 
kinases, phosphatases and caspases, where gain or loss of function through 
cleavage and phosphorylation controls the balance between life and death of the cell 
(Kurokawa and Kornbluth, 2009).   
 
 
5.2.4 Definition of the caspase-1 restriction site 
Compared to the N-terminal fragment produced by caspase-6 the cut executed by 
caspase-1 had to be around 20 kD (~180 amino acids) more C-terminal [Figure 25A 
and Figure 29, left panels]. To further verify the location, five overlapping GST-
tagged parts of ARTD10 where expressed in E. coli and used in an in vitro caspase 
assay similar to Figure 25B, where fragment 2 was used. Only part 3 encompassing 
amino acids 408-649 was cleaved by caspase-1 into an approximately 6-12 kD 
shorter protein. With an average molecular weight of 110 Dalton per amino acid this 
would suggest that the cleavage site is located somewhere between amino acids 540 
and 595. Consistently GST-fragment 4 encompassing amino acids 600 to 868 was 
not cleaved.  
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Figure 30. In vitro caspase assay with caspase-1 and purified ARTD10 GST-fragments. 
5 different overlapping GST-fragments, about 250 amino acids in size, covering ARTD10 were used in a caspase 
assay with and without recombinant caspase-1. The assay was stopped using sample buffer, the samples 
separated in SDS-PAGE and the proteins subsequently stained with coomassie brilliant blue. 
 
Taking into account the studies conducted by Shen et al. the surroundings of the 5 
aspartates within the region of 540 to 595 were analyzed (Shen et al., 2010). Using 
probabilities for amino acids from positions P10 to P10’, which were calculated using 
caspase-1 substrates, scores were made for the possible site in ARTD10. The two 
sites with the highest scores, amino acids 555 and 581, were mutated to glycine. 
 
 
 
Figure 31. In vitro caspase assay with different restriction site mutants for the caspase-1 site. 
HA-ARTD10 and mutants thereof were immunoprecipitated from transiently transfected HeLa cells. The samples 
were used in a caspase assay with caspase-1 and ARTD10 was detected in an immunoblot using the N-terminal 
5H11 antibody. 
 
Similar to Figure 29 wild-type ARTD10 and the two new mutants were tested in an in 
vitro caspase assay. As the bigger caspase-1 fragment was visible in all protein 
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sources used so far, only HeLa cells were transfected with the constructs. Western 
blot analysis revealed that the ARTD-D555G was still targeted by caspase-1 whereas 
the mutation of D581 abolished the caspase-mediated cleavage, confirming it as the 
cleavage site [Figure 31]. 
 
 
Caspase-1, together with caspases 4 and 5, belongs to the group of inflammatory 
caspases that mediate the processing and release of pro-inflammatory cytokines like 
IL-1β and IL-18 in response to a variety of stimuli [see also 4.3]. Although the exact 
mechanism is not known the caspase-1-mediated cleavage is commonly thought to 
represent an unconventional way of secretion (Keller et al., 2008). The data in this 
chapter showed ARTD10 as caspase-1 target in vitro and the associated cleavage 
site was mapped to ‘W T P D581 / S T’. Follow-up experiments with overexpressed 
ARTD10 in HeLa cells as well as endogenous protein in THP-1 cells were not 
successful, i.e. did not show the observed fragmentation of ARTD10. In those 
systems the expression of inflammasome components was stimulated with LPS, 
monitored by IL-1β production. The activation of the inflammasome with described 
secondary stimuli like nigericin and ATP as well as a subsequent release of pro-
inflammatory cytokines however could not be shown (Bauernfeind et al., 2011a). 
Therefore preemptive conclusions, that ARTD10 is not cleaved by caspase-1 in vivo 
should not be made and further experiments are in need. Like the caspase-6 
cleavage the processing by caspase-1 separates the RRM and glycine-rich region 
from the NES, UIMs and catalytic domain with the difference that the nuclear 
targeting sequence represented by amino acids 435-528 localizes to the N-terminal 
fragment (Kleine et al., 2012). This should have a crucial impact on the localization of 
the fragments and subsequently could change the biological function of ARTD10. A 
similar fluorescently labeled fragment from amino acids 552-1025 described in Kleine 
et al. shows a strictly cytoplasmic localization even when Leptomycin B is applied, a 
treatment which results in nuclear accumulation of the wild-type protein through 
inhibition of NES mediated export. The fragment from amino acids 1-581 on the other 
hand should now locate to the nucleus due to the NLS, regardless of the 
Leptomycin B status. Similar to the fragment 435-555 visualized in 
immunofluorescence microscopy during the same study it could also distribute 
throughout the cell depending on the strength of the NLS (Kleine et al., 2012). A 
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changed cellular function of the single fragments compared to the full-length protein 
linked to their different localization would represent an interesting gain of function 
mechanism.  
Another possibility taking into account the involvement of the inflammasome in 
unconventional protein secretion would be the externalization of parts of ARTD10. 
Especially the C-terminal fragment containing the catalytic domain would fit into a 
model where ARTD10 upon an inflammatory stimulus is cleaved, secreted and 
subsequently modifies targets outside the cell. Of note is that the ARTD10 substrate 
screen revealed several secreted proteins. Among those was for example PDGF-B, 
which could be verified in experiments with recombinant protein (Feijs et al 
submitted). ADP-ribosylation of soluble factors or cell-surface receptors outside off 
cells is well described and mediated by the so-called ecto-mARTs (Zolkiewska, 2005). 
The secretion of ARTD10 or parts of it with maintained catalytic activity would provide 
an explanation for where ARTD10 and extracellular proteins could interact. In 
contrast to these models a loss of function as was discussed for the caspase-6 
cleavage site could also be true for inflammation-linked cleavage of ARTD10. Taking 
into account its inhibitory effect on the pro-inflammatory NF-κB pathway, cleavage 
and inactivation of ARTD10 as part of an inflammation activation loop would be a 
mechanism worth considering (Verheugd et al. submitted). In analogy to the 
discussion regarding the connection of NF-κB, ARTD10 induced cell death and p62 
(5.1.3) it is of note that the latter protein is also involved in the regulation of the 
inflammasome (Shi et al., 2012). Upon aggregation polyubiquitination of the 
inflammasome complex recruits p62 and subsequently autophagy is triggered, which 
is thought to regulate inflammasome activity. As stated before colocalization of 
ARTD10 bodies with p62 bodies was shown and could provide the foundation of a 
model wherein p62 links ARTD10 to sites of active caspase-1 (Kleine et al., 2012). 
 
 
5.3 Cleavage of ARTD10 and cell viability 
ARTD10 induced apoptosis in HeLa cells and at the same time was targeted by 
caspases during the process. To address whether the cleavage of ARTD10 
diminished its pro-apoptotic properties additional stable HFT cells lines were 
established. The D406G mutant was used as non-cleavable ARTD10, as well as the 
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resulting fragments encompassing amino acids 1-406 and 407-1025. The cleavage 
at D406 resulted in the loss of the potential RNA recognition motif in the far N-terminal 
region [see Figure 3]. A fourth construct (ΔRRM) lacking this N-terminal part from 
amino acid 1-256 was generated to see whether the absence of this domain 
influenced the apoptotic effect. 
 
 
Figure 32. Growth curves of stable cell lines expressing different ARTD10 constructs. 
(A) HeLa cells expressing either ARTD10 or ARTD10-D406G were grown with or without doxycycline [200 ng/ml] 
over 5 days and counted each day. Two different clones of the mutant cell line were used. All experiments were 
done in triplicates. 
(B) HeLa cells expressing either ARTD10 or ARTD10 lacking the RRM and/or the glycine-rich region were grown 
with or without doxycycline [200 ng/ml] over 5 days and counted each day. All experiments were done in 
triplicates. 
 
Proliferation assays conducted with the new HFT cells revealed that the non-
cleavable mutant of ARTD10 inhibits proliferation [Figure 32A]. Similar to 
experiments done before the two clones used showed a slightly different growth rate. 
Addition of doxycycline resulted in the loss of cell proliferation approximately at the 
same rate as the cells expressing the wild-type ARTD10. In contrast the two 
fragments either lacking the RRM and glycine-rich region or the RRM alone did not 
show any inhibitory effect [Figure 32B]. The cells expressing the N-terminal fragment 
1-406 were not used in this experiment, as the growth inhibitory effect was 
dependent on catalytic activity. 
To rule out the possibility of different expression levels influencing this effect all 
constructs were expressed over 24 hours and detected by western blotting [Figure 
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33A/B]. All full-length constructs were detected with the polyclonal E09 antibody and 
show an equal expression level [Figure 33A]. The fragment protein levels were 
compared to the wild-type protein using the C-terminal antibody 9E12 as the epitope 
for the E09 antibody is lost [Figure 33B]. The visible ARTD10 reflected the sizes of 
the constructs and showed, when standardized to the tubulin control blot, an equal 
expression.  
 
 
Figure 33. Expression comparison of different ARTD10 constructs. 
(A) The expression of ARTD10, ARTD10-G888W, ARTD10-D406G was analyzed in lysates of uninduced and 
induced stably transfected HeLa cells. The full-length proteins were analyzed using the polyclonal antibody E09. 
GAPDH detection was used as loading control. 
(B) Same as in (A) with C-terminal fragments ARTD10-(407-1025) and ARTD10-(257-1025) and detection by the 
C-terminal 9E12 antibody and γ-Tubulin was used as loading control. 
(C) Expression comparison of wt3 and HFT cells expressing ARTD10-(1-406). Expression was induced for 24 h 
using different amounts of doxycycline. Proteins were detected using the monoclonal 5H11 antibody. GAPDH 
detection was used as loading control. 
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The HFT-ARTD10-(1-406) cells were additionally tested using different 
concentrations of doxycycline and subsequently compared to the expression of full-
length ARTD10 in wt3 cells [Figure 33C]. 
 
The reduced growth rate is as mentioned in chapters 5.1.2 as well as 5.1.3 not 
sufficient to make further conclusions regarding the reason for the diminished growth. 
Therefore the cells were used in FACS experiments were simultaneously dead cells 
were stained by propidium iodide and apoptosis could be measured and quantified 
by cell cycle analysis, i.e. measurement of the sub-G1 cells. All HFT cells containing 
the different constructs were induced for ARTD10 expression over 24 or 48 hours. All 
cells including non-adherent cells were collected and simultaneously stained with PI 
(50 µg/ml) and Vybrant Dyecycle Violet in standard culture medium for 30 minutes at 
a cell density of 106 cells/ml. The cells were subjected to FACS analysis and the 
percentage of PI positive cells was quantified [Figure 34B, upper panel]. Similar to 
the results obtained from the growth curve experiments above ARTD10 and 
ARTD10-D406G showed an increase of cells with lost cell membrane integrity up to 
around 40%. This toxic effect was neither induced by the catalytically inactive mutant, 
which was also assessed before [see 5.1.3], nor by any other used construct. The 
rate of apoptotic cells analyzed by quantification of the sub-G1 peak was comparable 
to the cell death rates and again only observed using the wild-type and D406G 
mutant which was in line with the growth curves [Figure 33B, lower panel]. 
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Figure 34. N-terminal truncation of ARTD10 abolishes apoptosis induction. 
Stable cells lines containing different ARTD10 transgenes were induced for the indicated times with doxycycline. 
Subsequently the cells were analyzed by FACS. Dead cells were stained with propidium iodide, gated and 
counted (Upper panel). The number of sub-G1 cells in was calculated in the cell cycle visualized by Vybrant 
Dyecycle Violet stain (Lower panel). 
 
A potential lack of cytotoxicity of the ARTD10 C-terminal fragments could be due to 
lost catalytic activity, which would as well abolish apoptosis. Evidence pointing 
towards an active protein comes from experiments using the GST-purified catalytic 
domain, a fragment ranging from amino acid 818-1025. This protein obtained from 
E. coli is catalytically active and was repeatedly used in ADP-ribosylation assays in 
our group. To ensure the functionality of the catalytic mechanism regarding the 
ARTD10 fragment 407-1025 GFP-tagged versions of ARTD10 wild-type, -G888W 
and -(407-1025) were expressed in U2OS cells to circumvent any toxic effects and 
immunoprecipitated using a GFP antibody. The obtained protein was used in an 
radioactive ADP-ribosylation assay with either active GST-ARTD10-(818-1025) as 
positive control or GST-ARTD10-(818-1025)-G888W as substrate. Not only was the 
C-terminal fragment active in this setup, but normalized to the protein amounts visible 
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in coomassie staining the catalytic activity seemed to be comparable to the one of 
the full length protein [Figure 35]. 
 
 
Figure 35. Activity comparison of ARTD10 and its caspase-6 fragment ARTD10-(407-1025). 
U2OS cells were transfected with vectors expressing GFP-ARTD10, -G888W, –(407-1025) or the respective 
control vector. After 24 hours the cells were lysed with TAP-lysis buffer and ARTD10 was immunoprecipitated 
using a GFP antibody and IgG sepharose beads. Following washing steps the beads were subjected to a PARP 
assay containing either GST-ARTD10-(818-1025) in the case of the vector control or catalytically inactive GST-
ARTD10-(818-1025)-G888W in the case of the GFP-ARTD10 proteins. The proteins were separated using 
SDS-PAGE. The gel was subsequently dried and incubated with medical X-ray films for different time periods. 
 
Given the maintained catalytic activity of the caspase-cleaved fragment, the question 
arises why these N-terminally truncated mutants of ARTD10 are incapable of 
inducing apoptosis. During the cleavage the RRM as well as the glycine-rich region 
of ARTD10 are separated from the rest of the protein [Figure 3], indicating their 
possible functional relevance. RRMs belong to a group of RNA binding domains that 
are found in proteins involved in divers aspects of RNA metabolism, ranging from 
splicing and editing to export, translational regulation and degradation (Finn et al., 
2006; Maris et al., 2005). They mainly interact with RNA, hence their name, but 
certain RRMs were also reported to bind to DNA or proteins (Clery et al., 2008). A 
combination with glycine-rich regions, like in ARTD10, is also reported for many other 
proteins in eukaryotes and this additional domain either assists in binding or confers 
binding itself (Cartegni et al., 1996; Dreyfuss et al., 1993; Kim et al., 2007; Mangeon 
et al., 2010). Some of these proteins including members of the hnRNP family are 
targets of caspases (Luthi and Martin, 2007; Van Damme et al., 2005). This is part of 
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a broad response in apoptotic cells to halt many house keeping processes in order to 
allow efficient apoptosis (Taylor et al., 2008). The processing of ARTD10 during 
apoptosis could be associated with an analogue mechanism, wherein the RRM 
and/or the glycine-rich region provide a vital function to the protein, which is 
abolished after cleavage. Activity changes upon binding of an interaction partner, be 
it RNA, DNA or protein, could be such a function, but initial experiments with sheared 
salmon sperm DNA, plasmid DNA or total cellular RNA did not alter activity 
dependent on the RRM (Kleine et al., 2008). Sequence specific binding or protein-
protein interaction however cannot be excluded by these experiments and the search 
for binding molecules would be an opportunity to get further insides into the 
molecular function of ARTD10.  
 
Considering the information about RRM containing proteins the N-terminal part of 
ARTD10 could also confer targeting and substrate recognition purposes. Interesting 
in this regard is the diminished development of the characteristic ARTD10 foci using 
ARTD10-(257-1025) or -(552-1025), a fact which led to the assumption that the RRM 
is important for localization (Schuchlautz, 2008). However colocalization of the full 
length ARTD10 foci with common RNA containing bodies like P-bodies or stress 
granules could not be shown (Kleine et al., 2012). Nonetheless the involvement of 
ARTD10 in an RRM directed process seems likely and the extensive shuttling 
between nucleus und cytoplasm could place ARTD10 in a model wherein it regulates 
the export or import of RNA (Kleine et al., 2012). At last the deregulation of an 
essential housekeeping function through overexpression of ARTD10 could also 
explain the onset of apoptosis, an assumption which is strengthened by the fact that 
also the knockdown of ARTD10 interferes with cell proliferation (Feijs, 2009). 
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6 Conclusions 
ARTD10 was reported to inhibit proliferation in HeLa cells upon overexpression (Yu 
et al., 2005). Expanding on these earlier findings using stable inducible HeLa cell 
lines this work showed that the prior observed effect is due to the induction of 
apoptosis. The mono-ADP-ribosylation as catalytic activity of ARTD10 has proven to 
be essential as the catalytic inactive mutant ARTD10-G888W does not drive these 
cells into programmed death. Modifications of the protein, e.g. lysine depletion or 
destruction of UIM, NES or NLS, abolish the apoptotic phenotype as well, hinting at 
the importance of the overall structural integrity of ARTD10. Although it is possible 
that a protein’s function is dependent on all of its domains, conclusions on the 
underlying mechanisms are complicated.  
The main question in this regard comes back to whether ARTD10 itself is involved in 
apoptosis regulation or whether the cell death is just the effect of ARTD10’s 
overexpression, i.e. the disturbance of a basic vital cellular pathway? Taking into 
account the late onset of cell death after 24 hours and the relatively high numbers of 
cells surviving ARTD10 overexpression, a direct pro-apoptotic function of ARTD10 
seems unlikely. The little information on physiological functions of ARTD10 however 
allows the discussion of several indirect links to apoptosis. Inhibition of NEMO 
ubiquitination and p65 translocation could be responsible for the shutdown of an 
essential residual NF-κB activity in those tumor cells (Verheugd et al. submitted). p62, 
a poly-ubiquitin adapter protein functioning in different pathways including pro-
survival signaling through NF-κB, colocalizes with ARTD10 bodies and links 
ARTD10’s function to NF-κB regulation (Duran et al., 2008; Kleine et al., 2012). The 
mentioned bodies are also known to decrease in numbers when the RRM is deleted 
in ARTD10. Although known RNA containing dot structures in the cytoplasm were 
ruled out, the involvement of ARTD10 in RNA processing is a valid option and the 
disturbance of this basic cellular process could explain apoptosis (Kleine et al., 2012). 
In addition ARTD10 modifies several mitosis-regulating kinases, whose functional 
inhibition is known to induce apoptosis or error prone mitosis, the latter of which 
would fit to the 24 hours cell death delay in the HeLa model system. 
These models will have to be investigated in future studies to pinpoint ARTD10’s 
exact function in cellular pathways and induction of apoptosis. 
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During the work with apoptosis we noted that ARTD10 was cleaved at ‘I A M D406 S P’ 
into two fragments. Analogous to the processing of ARTD1 this was mediated by 
caspases, the main effectors during apoptosis. Both fragments were rather stable 
and appeared in a time window in response to apoptotic signals that was similar to 
ARTD1 cleavage. The N-terminal part contained the RRM as well as the glycine-rich 
region, separating a possible interaction with RNA or other macromolecules from the 
catalytic domain. Surprisingly, although the catalytic activity was maintained, the 
overexpression of the C-terminal part of ARTD10 did not lead to the induction of 
apoptosis. With this knowledge a model wherein ARTD10 is directly involved in the 
apoptotic process becomes even more unlikely, as the inactivation of a pro-apoptotic 
protein during apoptosis is hard to explain. The separation of the RRM however 
could very well influence a possible targeting or regulation of ARTD10 and 
subsequently its ability to modulate an important cellular pathway. 
Using in vitro caspase assays we could demonstrate that predominantly caspase-6 is 
responsible for cleavage at D406. This caspase, apart from its functions as 
executioner during apoptosis, is also implicated in neuronal development, i.e. axonal 
breakdown and neurodegenerative diseases. Targeting of ARTD10 outside the 
normal apoptotic process is an interesting possibility and would clear the way for 
studies analyzing ARTD10’s role in the neuronal system. 
 
Using recombinant caspases we observed an additional cleavage of ARTD10 by 
caspase-1, the best characterized member of the inflammatory caspases. The target 
site was located 175 amino acids further C-terminal in the protein to 
‘W T P D581 / S T’, placing the NLS (435-528) in the N-terminal fragment. This small 
difference should have an impact on its localization, abrogate shuttling of the 
C-terminal part, and subsequently influence their functions. As yet the in vivo 
processing by caspase-1 could not be shown, but a role of ARTD10 in inflammation, 
linking perhaps NF-κB signaling and the inflammasome, is an interesting path to 
follow in future studies. In addition the unconventional protein secretion mediated by 
caspase-1 cleavage is commonly known (Keller et al., 2008). Releasing parts of 
ARTD10 containing the catalytic domain from the cell would facilitate explanations on 
how ARTD10 meets its substrates that are secreted. 
Findings in our group revealed that ARTD10 is heavily modified by acetylation, 
ubiquitination and phosphorylation, the latter of which could play a role in regulating 
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caspase-mediated cleavage through modification of the serines in P1’ or the 
threonine in P2’. The questions whether these sites are actually targeted in cells and 
which kinases and pathways potentially act, will have to be addressed in future 
studies. 
 
In conclusion the HeLa system used throughout this study helped us to make a step 
forward in understanding the physiological role of ARTD10 by showing that ARTD10 
induction leads to apoptosis and that ARTD10 is cleaved itself during this process. 
These results provide new starting points for further interesting studies connecting 
ARTD10 to apoptosis, RNA metabolism or inflammation. Additionally, this cell system 
will be highly useful in order to solve upcoming questions. 
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7 Experimental procedures 
Materials and Methods are described according to standard protocols used in the 
Institute of Biochemistry and Molecular Biology, RWTH Aachen University, and 
modified regarding individual differences in experimental procedures. 
 
7.1 Oligonucleotides 
 Sequence (5’à3’) 
 
Mutagenesis of D406G in ARTD10 
PARP10_D406G GTGGAAATTGCCATGGGCTCACCAGAGCAAGAG 
PARP10_D406G_antisense CTCTTGCTCTGGTGAGCCCATGGCAATTTCCAC 
  
Mutagenesis of D581G in ARTD10 
D581G CCTGTGGACCCCAGGCAGTACAGGTGGTG 
D581G_antisense CACCACCTGTACTGCCTGGGGTCCACAGG 
  
Amplification of attB-PARP10 
attB1-PARP-10 GGGGACAAGTTTGTACAAAAAAGCAGGCTCCATGGTTGCAATGGCGGAGG 
attB2-PARP-10 GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAAGTGTCTGGGGAGCGGC 
  
Amplification of attB-PARP10_1-406 
attB1-PARP-10 GGGGACAAGTTTGTACAAAAAAGCAGGCTCCATGGTTGCAATGGCGGAGG 
attB2_ARTD10_1-406 GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAGTCCATGGCAATTTCCACCAG 
  
Amplification of attB-PARP10_407-1025 
attB1-PARP10_407-1025 GGGGACAAGTTTGTACAAAAAAGCAGGCTCCTCACCAGAGCAAGAGGGGCTG 
attB2-PARP-10 GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAAGTGTCTGGGGAGCGGC 
  
Amplification of attB-PARP10_407-1025+M 
attB1-ARTD10_407+M GGGGACAAGTTTGTACAAAAAAGCAGGCTCCATGTCACCAGAGCAAGAGGGGCTGGTGGGTCC 
attB2-PARP-10 GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAAGTGTCTGGGGAGCGGC 
 
7.2 Plasmids 
Vector Reference 
GW-pEGFP 
Gateway compatible expression vector established by 
insertion of the Gateway cassette B into peGFP-C1 
(Clontech) 
pBabePuro (Morgenstern and Land, 1990) 
pEQ176P2 Derivate of pEQ176 (Schleiss et al., 1991) lacking a greater part of ß-galactosidase (J. Lüscher-Firzlaff) 
Experimental procedures  79 
pOG44 Mammalian expression vector encoding the Flp recombinase (Invitrogen) 
pcDNA5/FRT/TO Mammalian expression vector used for integration of a target gene into the FRT site of Flp-In™ cells (Invitrogen) 
pDonR/Zeo Standard donor vector in the Gateway® cloning system (Invitrogen) 
pcs2+p27 Vector driving the expression of p27 under the control of a CMV promoter (J. Vervoorts). 
pEVRF0-HA (Matthias et al., 1989) 
GW-pcDNA5/FRT/TO 
Gateway® compatible pcDNA5/FRT/TO with the 
Gateway® cassette A cloned into blunted HindIII site. (A. 
Forst) 
pEVRF0-HA-ARTD10 (Yu et al., 2005) 
pEVRF0-HA-ARTD10-G888W (Yu et al., 2005) 
pEVRF0-HA-ARTD10-ΔNES (Schuchlautz, 2008) 
pEVRF0-HA-ARTD10-ΔUIM (Milke, 2007) 
pEVRF0-HA-ARTD10-Δ219-502 Expression vector for ARTD10 lacking the amino acids 219-502 
pEVRF0-HA-ARTD10-ΔK (Chauvistré, 2008) 
pEVRF0-HA-ARTD10-D406G Constructed using site directed mutagenesis 
pEVRF0-HA-ARTD10-D581G Constructed using site directed mutagenesis 
pcDNA5/FRT/TO-ARTD10 
Constructed from pcDNA5/FRT/TO and the respective 
pEVRF0-HA-ARTD10 plasmid using standard cloning 
techniques. 
pcDNA5/FRT/TO-ARTD10-G888W 
pcDNA5/FRT/TO-ARTD10-ΔNES 
pcDNA5/FRT/TO-ARTD10-ΔUIM 
pcDNA5/FRT/TO-ARTD10-Δ219-502 
pcDNA5/FRT/TO-ARTD10-ΔK 
pcDNA5/FRT/TO-ARTD10-D406G 
pcDNA5/FRT/TO-ARTD10-D581G 
pDonR/Zeo-ARTD10 (Montzka, 2006) 
pDonR/Zeo-ARTD10-G888W (Montzka, 2006) 
pDonR/Zeo-ARTD10-D406G Constructed by Gateway cloning (Primers see 7.1) 
pDonR/Zeo-ARTD10-1-406 Constructed by Gateway cloning (Primers see 7.1) 
pDonR/Zeo-ARTD10-407-1025 Constructed by Gateway cloning (Primers see 7.1) 
pDonR/Zeo-ARTD10-407-1025+M Constructed by Gateway cloning (Primers see 7.1) 
GW-peGFP-ARTD10 
Constructed by Gateway® cloning using GW-pEGFP and 
the respective pDonR/Zeo-ARTD10 construct. 
GW-peGFP-ARTD10-G888W 
GW-peGFP-ARTD10-D406G 
GW-peGFP-ARTD10-1-406 
GW-peGFP-ARTD10-407-1025 
GW-pGEX-PARP10-1 
Prokaryotic expression vector encoding GST-tagged 
fragments of ARTD10 (Montzka, 2006) 
GW-pGEX-PARP10 (206-459) 
GW-pGEX-PARP10 (408-649) 
GW-pGEX-PARP10 (600-868) 
GW-pGEX-PARP10 (818-1025) 
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7.3 Antibodies 
Antigen Antibody Species Type Provided by Order number Reference 
Actin C4 mouse monoclonal MP Biomedicals 69100  
ARTD10 891-6 rabbit polyclonal   (Yu et al., 2005) 
ARTD10 5h11 rat monoclonal E. Kremmer   
ARTD10 E09 rabbit polyclonal Eurogentec   
ARTD10 3H5 rat monoclonal E. Kremmer   
Flag M2 mouse monoclonal Sigma F-3165  
GAPDH 4G5 mouse monoclonal AbD Serotec MCA4740  
GFP 9F9.F9 mouse monoclonal Rockland 600-301-215  
HA-tag 3F10 rat monoclonal Roche 1 867 423  
PARP1  rabbit polyclonal Roche 11835238001  
α-Tub B-5-1-2 mouse monoclonal Sigma T-5168  
γ-Tub GTU88 mouse monoclonal Sigma T-6557  
Casp-1  rabbit polyclonal Millipore 06-503  
Casp-3 H-277 rabbit polyclonal Santa Cruz SC-7148  
Casp-6  rabbit polyclonal Cell Signaling CS#9762  
Casp-8 H-134 rabbit polyclonal Santa Cruz SC-7890  
 
Secondary antibodies used for immunodetection were HRP labeled goat-α-mouse 
(115-035-146), goat-α-rabbit (111-035-144) and goat-α-rat (112-035-008) antibodies 
purchased from Jackson Immunoresearch. A rat-IgG2a specific secondary antibody 
labeled with HRP was a kind gift of E. Kremmer. 
For immunofluorescence analysis goat-α-rat-Alexa-488 (Invitrogen) secondary 
antibody was used. 
 
7.4 Work with nucleic acids 
7.4.1 DNA preparation and extraction 
Zymo Research Zyppy™ Plasmid Miniprep Kit 
 Zymoclean™ Gel DNA Recovery Kit 
Macherey-Nagel NucleoBond® Xtra Maxi / Maxi Plus 
Invitrogen PureLink™ Quick Plasmid Miniprep Kit 
 
All kits were used according to the manufacturer’s manual. Samples, which were 
subjected to sequencing, where eluted with ddH2O to exclude any negative effects of 
EDTA in the elution buffer. DNA concentrations where measured using a 
NanoDrop™ 1000 Spectrophotometer (PeqLab). 
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7.4.2 RNA preparation, cDNA synthesis and RT-PCR 
Qiagen QIAshredder 
 RNeasy Mini Kit 
 RNase-Free DNase Set 
 QuantiTect Reverse Transcription Kit 
Diagenode 2x Universal Mastermix  
 
RNA purification was performed using Qiagen Qiashredder columns and the RNeasy 
Mini Kit following the manufacturer’s protocol with the optional on-column DNase 
digestion. cDNA synthesis was carried out using 1 µg RNA. RT-PCR was run on a 
Corbett Life Science Rotor-Gene 6000 in a 10 µl reaction volume containing 1 µM of 
each primer and 2 µl of 1:100 diluted cDNA. 
 
7.4.3 Molecular cloning 
Restriction enzymes from either NEB or Fermentas were used according to the 
manufacturer’s protocol in a total volume of 10 µl. Ligations were performed using T4 
DNA ligase (Fermentas) for 1 hour at room temperature. In the case of blunt end 
ligation, vector backbones were treated first with FastAP™ Thermosensitive Alkaline 
Phosphatase (Fermentas) and PEG2000 was added to the reaction mixture (1:10). 
 
7.4.4 Agarose gel electrophoresis 
TBE: 89 mM Tris-Base  
 89 mM boric acid 
 2 mM EDTA 
  
Agarose Low EEO (Applichem)  
O'GeneRuler™1 kb Plus DNA Ladder, ready-to-use, 75-20,000 bp (Fermentas) 
 
Depending on the separating capacity needed, different agarose concentrations 
ranging from 0.8 to 2 % were used. If not indicated otherwise O'GeneRuler™ 1 kb 
Plus DNA Ladder was used as DNA marker.  
 
7.4.5 Gateway cloning 
Gateway cloning was performed using pDONR™/Zeo following the manufacturer’s 
protocol. Due to the high performance all reactions were done with half the 
recommended volumes. 
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Invitrogen Gateway® BP Clonase® enzyme mix  
 Gateway® LR Clonase® enzyme mix  
 pDONR™/Zeo 
 
AttB products were generated using the Finnzymes Phusion Polymerase, the 
respective attB1/attB2 primers [7.1] and a vector containing the target gene in a PCR 
with standard conditions. 
 
7.4.6 Site-directed mutagenesis 
Primers for mutagenesis were designed using the QuikChange Primer Design 
program (Agilent Technologies). PCR was performed using Finnzymes Phusion 
polymerase with standard conditions. Following the amplification the methylated DNA 
was digested with DpnI and E. coli DH5α were transformed. 
 
7.5 Work with prokaryotic cells 
7.5.1 Bacteria strains 
E. coli Bl21 (DE3)pLysS 
(Stratagene) 
B F– dcm ompT hsdS(rB– mB–) gal λ(DE3) [pLysS Camr] 
 
 
E. coli DH5α 
(Invitrogen) 
F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
 
E. coli Rosetta-gami™ 
B(DE3)pLysS (Merck) 
 F– ompT hsdSB (rB– mB–) gal dcm lacY1 ahpC (DE3) gor522::Tn10 
trxB pLysSRARE (CamR, KanR, TetR)  
 
E. coli Xl10-Gold 
(Stratagene) 
TetrΔ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 
gyrA96 relA1 lac Hte [F´ proAB lacIqZΔM15 Tn10 (Tetr) Amy Camr] 
 
7.5.2 Standard materials 
LB Medium: 1 % (w/v) tryptone 
 0.5 % (w/v) yeast extract 
 1 % (w/v) NaCl 
 pH7.0 
  
Experimental procedures  83 
Low Salt LB Medium: 1 % (w/v) tryptone 
 0.5 % (w/v) yeast extract 
 0.5 % (w/v) NaCl 
 pH 7.5 
  
Agar plates (Amp/Kan): LB Medium  
 1.5 % (w/v) Bacto Agar (Applichem)  
 100 µg/ml ampicillin (Binotal) or 30 µg/ml kanamycin 
(Seromed) 
  
Agar Plates (Zeo): Low Salt LB Medium 
 1.5 % (w/v) Bacto Agar (Applichem) 
 50 µg/ml zeocin (Invivogen) 
 
7.5.3 Transformation 
100 µl chemically competent bacteria were thawed on ice and mixed with either 
500 ng plasmid DNA or 20 µl of ligation mixture. After 30 minutes on ice, the bacteria 
were incubated for 45 seconds at 42°C, cooled on ice again for 2 minutes and 
afterwards directly plated on agar plates containing the appropriate antibiotic. The 
plates were then incubated over night at 37°C. 
 
7.5.4 GST-purification 
TNE Buffer: 20 mM Tris pH 8.0 
 150 mM NaCl 
 1 mM EDTA 
 5 mM DTT 
 1 mM Pefabloc SC (Roche) 
 14 µg /ml aprotinin 
  
GST Wash Buffer: 100 mM Tris pH 8.0 
 120 mM NaCl 
  
GST Elution Buffer: 100 mM Tris pH 8.0 
 120 mM NaCl 
 20 mM glutathione 
 
Colonies from E. coli Bl21 (DE3)pLysS or E. coli Rosetta-gami™ B(DE3)pLysS were 
picked and used for inoculation of a 50ml pre-culture containing a final glucose 
concentration of 0,4 % (w/v), which was grown over night at 37 °C. The next day a 
300 ml main culture was inoculated with 25 ml pre-culture. The culture was incubated 
further until an OD600 of 0,5-0,8 and 1 mM IPTG was added to induce protein 
expression over night. 
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The cells were harvested at 3500 xg at 4 °C, resuspended in 30 ml TNE-buffer and 
100 µg/ml lysozyme was added, before chilling on ice for 30 minutes. 
The cells were disrupted by sonication and cell debris was removed by centrifugation 
at 10,000 xg for 30 minutes. 500 µl Glutathione Sepharose 4B beads (Amersham 
Biosciences) were added to the supernatant and the mixture was rotated for 1 hour 
at 4 °C. Washing of the beads was performed with 1 ml ice cold PBS + 1 % (v/v) 
Triton X-100 and 1 ml GST wash buffer. The purified protein was eluted with three 
times 300 µl GST elution buffer and subsequently stored at -80 °C. Purity and 
concentration of the desired protein were checked by SDS-PAGE and coomassie 
staining with a BSA standard. 
 
 
7.6 Work with eukaryotic cells (cell culture) 
7.6.1 Eukaryotic cell lines 
Cell line ATCC Reference 
HEK293-C-TAP-ARTD10  (Kleine et al., 2008) 
HEK293-C-TAP-ARTD10-G888W  (Kleine et al., 2008) 
HeLa CCL-2™   
HeLa Flp-In T-Rex  Steven Taylor, University of Manchester 
THP-1 TIB-202™     
U2OS HTB-96™  
 
Stable inducible cell lines using the Flp-In T-Rex system (Invitrogen) were selected 
using 5 µg/ml blasticidin and 200 µg/ml hygromycin. After initial selection monoclonal 
cells were established. Therefore cells were seeded at a very low density and grown 
until visible colonies emerged from single cells. The colonies transferred to new 
separate wells using cloning rings. 
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7.6.2 Standard materials 
PBS: 140 mM NaCl  
 2.6 mM KCl 
 2 mM Na2HPO4 
 1.45 mM KH2PO4 
  
1.2 ml cryotubes (Thermo scientific)  
Blasticidin S (Invivogen)  
DMEM (Gibco) with 4,5 g/l Glucose   
Doxycycline (Sigma)  
Etoposide (Calbiochem)  
FCS (Gibco)  
Hygromycin B (Invivogen)  
10,000 µg/ml Penicillin / 10,000 U/ml Streptomycin (Gibco) 
RPMI + Glutamax (Gibco)  
Staurosporine (Biomol)  
Tissue culture dishes (Sarstedt)  
Tissue culture plates (Sarstedt)  
Trypsin (Gibco)  
 
7.6.3 Cell culture 
All cell lines were cultured at 37 °C with 5 % CO2. RPMI medium was used for 
THP-1 cells. DMEM-Glutamax I medium was used for all other cell lines. All media 
were supplemented with 10 % FCS and 1 % penicillin/streptomycin. 5 µg/ml 
blasticidin and 100 µg/ml hygromycin (200 µg/ml for initial selection) were added as 
selection markers to the medium of the stable cell lines. Transfections of plasmids 
were carried out using the calcium phosphate method. UV was applied on PBS 
washed cells using 20 mJ/cm2 at 254 nm. 
 
7.6.4 Cryoconservation 
Cells were grown on 10 cm dishes to density of roughly 70 %. They were trypsinized, 
spun down (200 xg, 2 minutes) and subsequently resuspended in 1 ml FCS 
containing 10 % DMSO. The cells were slowly frozen in cryotubes to -80 °C using 
styrofoam boxes. After 3-4 days they were transferred to a -150 °C freezer for 
longterm storage. 
Thawing of the cells was achieved by quickly raising the temperature to 37 °C in a 
waterbath and transfer to pre-warmed medium. To get rid of residual DMSO the 
medium was changed directly by centrifugation. 
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7.6.5 Calcium phosphate transfection 
HEBS buffer: 138 mM NaCl 
 17 mM Hepes 
 5 mM KCl 
 0.71 mM Na2HPO4 2 H2O 
 pH 6.95 
  
  
HEPES buffer: 142 mM NaCl  
 10 mM HEPES 
 6.7 mM KCl 
 pH 7.3 
  
2.5 M CaCl2  
 
To introduce plasmid DNA into cells the calcium phosphate precipitation method was 
used routinely. Amounts of total DNA and buffers, as wells as number of cells, 
depend on the area of the dishes used. Cells were seeded at an approximate density 
of 8-10 x104 cells per cm2. 0.25 µg/cm2 total plasmid DNA were mixed with 
11.875 µl/cm2 HEBS buffer. 0.625 µl/cm2 2.5 M CaCl2 was added afterwards and 
vortexed. The suspension was incubated between 20-40 minutes at room 
temperature before the dropwise application to the cells. The ratio between 
transfection mixture and medium should be at 1:10. 
 
7.6.6 Colony formation assay 
Stable HeLa cells expressing the different ARTD10 proteins were seeded at the 
indicated cell number and treatment was started with 1 µg/ml doxycycline. Medium 
was changed after 4 days. On day 11 the cells were washed and subsequently 
stained with 0.2 % methylene blue in methanol for 30 minutes. The staining solution 
was removed by washing with ddH2O and afterwards dried and scanned for 
documentation. 
In colony formations with transfected cells, HeLa cells were seeded in 6-well plates at 
a density of 80,000 cells per well. The following morning the cells were transfected 
with 2.5 µg total plasmid DNA, including 0.25 µg puromycin resistance vector 
(pBabePuro) using the calcium phosphate transfection. After 24 hours the cells were 
washed with HEPES buffer and subsequently selected with medium containing 
puromycin (2 µg/ml, Sigma) for another 24 hours. Medium was replaced during the 
following days as necessary. At a density on the control plate (puromycin resistance 
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vector only) of roughly 90 % the colonies were stained and digitized as described 
above. Density was quantified using the free software ImageJ (v1.46). 
 
7.6.7 Cell proliferation assays 
HeLa cells were seeded at a density of 3 x 104 cells/well for each counting day in 
triplicates. Protein expression was induced by addition of doxycycline (1 µg/ml). The 
cell count on the respective plates was determined each day after trypsinization 
using the CASY® Technology Cell Counter with 3 measurements per sample.  
For analysis of the cell cycle the respective clones were seeded in 6 cm dishes at a 
density of 1 x 104 cells/dish. Expression of the proteins was induced by doxycycline 
(0.2 µg/ml) for 0-72 hours. The cells were trypsinized from the plates and harvested 
by centrifugation (200 xg, 2 minutes) including the cells from the supernatant. They 
were stained with Vybrant Dyecycle Violet (1 µl/106 cells in 1 ml DMEM) (Invitrogen) 
and propidium iodide (PI) (50 µg/ml) for 30 minutes in the dark and subsequently 
measured using a FACSCanto II. Analysis and quantification of the PI positive cells 
and the subG1-peak was done using FlowJo (v8.8.7).  
Early apoptotic cells were detected using an annexin V binding assay. The cells were 
seeded in 6 cm dishes at a density of 8 x 104 cells/dish, incubated for 24 hours and 
then stimulated with 1 µg/ml doxycycline for 3 days. Control cells were treated with 
20 µM etoposide. At the indicated time points the cells were treated using the FITC 
Annexin V Apoptosis Detection Kit I (BD Pharmingen) and measured by FACS. 
Annexin V / PI negative cells were quantified using FlowJo (v8.8.7). 
 
7.7 Work with proteins 
7.7.1 Cell lysis and immunoprecipitations 
RIPA: 10 mM Tris-HCl, pH 7.4 
 150 mM NaCl 
 1 % NP-40 
 1 % DOC 
 0.1 % SDS 
 0.5 % Trasylol 
 ProteoBlock™ Protease Inhibitor Cocktail (Fermentas) 
 
Cells were routinely lysed in 12,5 µl/cm2 RIPA buffer containing a protease inhibitor 
cocktail on ice. The cells were scraped from the plates and sonified for 15 minutes 
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using a BioRaptor (Diagenode) to destroy the genomic DNA and afterwards cleared 
by centrifugation at 16,100 xg.  
 
Lysates used for immunoprecipitation of proteins were incubated with IgG sepharose 
(Amersham Biosciences) and a specific antibody at 4 °C for at least 16 hours. The 
beads were washed twice with RIPA and twice with high salt RIPA buffer (containing 
500 mM NaCl), followed by a washing step with the assay specific buffer. To ensure 
the catalytic activity of ARTD10, the immunoprecipitations for PARP assays were 
done using TAP lysis buffer [7.7.5] instead of RIPA during all steps. 
 
7.7.2 SDS-PAGE 
4x Sample Buffer: 320 mM Tris, pH 6.8 
 40 % (v/v) glycerol 
 8 % (w/v) SDS 
 0.5 % (w/v) BPB 
 200 mM ß-Mercaptoethanol 
  
Running Buffer (Laemmli): 25 mM Tris base 
 250 mM glycine 
 0.1 % (w/v) SDS 
  
Protein Ladder: PageRuler Prestained Protein Ladder, 11-170 kDa (Fermentas) 
 
Separation of proteins was done by SDS-PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis) in Bio-Rad electrophoresis chambers. Samples 
were mixed with 4x sample buffer and boiled for 5 minutes at 98 °C before the 
application to the gel. Depending on the molecular size of the detected protein, 
separating gels from 10 to 15 % and a 5 % stacking gel were used.  
 
7.7.3 Western Blot and Immunodetection 
Semi-dry Transfer Buffer: 25 mM Tris base 
 192 mM glycine 
 20 % (v/v) methanol 
  
PBS-T: PBS 
 0.05 % (v/v) Tween-20 
  
Blocking Buffer: PBS-T 
 5 % (w/v) non-fat dried milk powder (Applichem) 
  
Ponceau S 0,2 % (w/v) Ponceau S in 3 % (v/v) Trichloroacetic acid 
ECL solutions (Pierce)  
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To detect separated proteins by specific antibodies, they were transferred onto 
nitrocellulose membranes (Whatman) by semi-dry blotting. The SDS-PAG and 
membrane were lined on each site with three layers of thin whatman paper 
(Whatman), soaked with semi-dry transfer buffer and blotted for 75 minutes at 
1.75 mA/cm2. 
Transferred proteins were transiently stained with Ponceau S to check the transfer 
efficiency. After blocking with blocking buffer for 30 minutes the blot was washed with 
PBS-T and agitated with the desired antibody at 4 °C over night. Antibody dilutions 
ranged from 1:200 to 1:5000 depending on the quality of the antibody. Following a 
second washing step, the appropriate HRP coupled secondary antibody was added 
in PBS-T at a dilution of 1:5000 and shaken for 60 minutes. Proteins were detected 
using Pico or Femto ECL solution (Pierce) and a LAS-3000 image reader (Fuji). 
 
7.7.4 Coomassie staining 
Staining Solution: 10 % (v/v) acetic acid 
 0.006 % (w/v) Coomassie brilliant blue G250  
Destaining Solution: 10 % acetic acid 
  
  
 
Visualization of purified proteins in SDS-PAGs was done by coomassie staining. The 
gels were incubated in staining solution for 1 hour, followed by incubation in 
destaining solution or ddH2O until the protein bands were clearly visible. The gels 
were dried on whatman paper under vacuum to store them. 
 
7.7.5 Tandem affinity purification 
TAP Lysis Buffer: 50 mM  Tris pH 7.5 
 150 mM NaCl 
 1 mM EDTA 
 10 % (v/v) glycerol 
 1 % (v/v) NP-40 
 1 mM DTT 
 100 µM sodium vanadate 
 14 µg/ml aprotinin 
 4 µM leupeptin 
 0.5 mM PMSF 
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TEV Buffer: 50 mM Tris pH 7.5 
 150 mM NaCl 
 0.5 mM EDTA 
 1 mM DTT 
  
Calmodulin Binding Buffer: 10 mM Tris pH 7.5 
 150 mM NaCl 
 0.2 % (v/v) NP-40 
 1 mM magnesium acetate 
 2 mM calcium chloride 
 1 mM imidazole 
 10 mM β-ME 
  
Calmodulin Wash Buffer: 50 mM ammonium bicarbonate pH 8.0 
 75 mM NaCl 
 1 mM magnesium acetate 
 1 mM imidazole 
 2 mM calcium chloride 
  
Calmodulin Elution Buffer : 50 mM ammonium bicarbonate pH8.0 
 25 mM EGTA 
  
IgG affinity matrix: IgG Sepharose 6 Fast Flow (Amersham Biosciences) 
  
Calmodulin affinity matrix: Calmodulin Sepharose 4B (Amersham Biosciences) 
 
 
HEK293-C-TAP-PARP10 (wildtype and G888W mutant) cells were grown in spinner 
culture. They were induced for expression of the protein by addition of 1 µg/ml 
doxycycline for 16 hours. The cells were harvested at 200 xg and 4 °C and washed 
with 20 ml ice-cold PBS. All following steps were carried out at 4 °C. 
 
After resuspension in 15 ml lysis buffer per 500 ml suspension culture, lysis was 
carried out with slight agitation for 30 minutes. The resulting lysate was cleared by 
centrifugation (20.000 xg, 4 °C, 20 min) and the supernatant was incubated with 
125 µl equilibrated IgG Sepharose 6 FF per 15 ml lysate for 1 hour under rotation. 
The beads were spun down (200 xg, 2 min) and washed three times with TEV buffer 
before resuspension in 5 volumes of TEV buffer. Approximately 200-500 ng of His-
tagged TEV protease (Invitrogen) per 10 µl beads was added and cleavage was 
carried out for 2 hours under permanent agitation. The beads were again separated 
and the supernatant transferred to a new tube containing equilibrated Calmodulin 
Sepharose 4B (equal volume as for IgG sepharose). The remaining IgG sepharose 
was washed with 3 volumes calmodulin binding buffer, which was also added tot he 
calmodulin sepharose after repeated separation.  
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With a CaCl2 concentration of 5 mM the suspension was incubated for 90 minutes. 
The beads were again spun down and washed 3 times with calmodulin wash buffer, 
before the final elution in 2 volumes elution buffer. The resulting supernatant with the 
eluted protein was stored with a final MgCl2 concentration of 25 mM at -80 °C. 
 
7.8 Enzymatic assays 
7.8.1 ADP-ribosylation assay 
2x Reaction Buffer: 100 mM Tris pH 8.0 
 0.4 mM DTT 
 8 mM MgCl2 
  
[32P]-NAD+ 370 MBq/ml (10 µCi/µl) (Perkin Elmer) 
ß-NAD+ (Sigma)  
 
The activity of ARTD10 was measured with incorporation of radioactive labeled NAD+. 
The immunoprecipitated proteins and substrates were incubated in 30 µl reaction 
volume at 30 °C. The reaction was carried out in ADP-ribosylation assay buffer 
containing additionally 50 µM ß-NAD+ and 1 µCi [32P]-NAD+. After 30 minutes the 
reaction was stopped by the addition of 4x sample buffer and the samples were 
subjected to SDS-PAGE. After coomassie staining and drying of the gel, medical 
X-ray films (Fujifilm, 100NIF) were used to visualize modified proteins. 
 
7.8.2 Caspase assay 
2x caspase reaction buffer 100 mM Hepes 
 100 mM NaCl 
 0.2 % Chaps 
 20 mM EDTA 
 5 % Glycerol 
 10 mM DTT 
 pH 7.2 
  
Caspases Set IV, human, recombinant (PromoKine) 
 
0.1 unit recombinant human caspase was used in a 30 µl volume, containing the 
protein of interest and buffered with caspase reaction buffer. After incubation for 1-2 
hours at 37 °C the reaction was stopped by addition of 4x sample buffer and the 
fragments were analyzed by SDS-PAGE followed by western blotting and 
immunodetection or a coomassie staining. 
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7.9 Immunofluorescence 
Fixing Solution: 3.7 % PFA in PBS 
Permeabilizing Solution: 0.1 % Triton-X100 in PBS 
Blocking Solution: 1 % BSA in Permeabilizing Solution 
Antibody Solution: 0.2 % BSA in PBS 
  
Hoechst 33258 [10 mg/ml] (Sigma)  
Mowiol 4-88 (Calbiochem)  
Glass coverslips  
PBS  
 
Cells were seeded on coverslips in a 12 well plate and induced for expression of 
ARTD10 for 4 hours. The slides were washed twice with PBS and the cells were 
fixed with fixing solution for 15-30 minutes. The PFA was removed by a washing step 
with permeabilizing solution and the coverslips were blocked with blocking solution 
for 30 minutes. The primary antibody was diluted 1:20 in antibody solution and 
applied to the coverslips before a 1 hour incubation at 37 °C.  The cells were again 
washed three times with antibody solution before the appropriate fluophore coupled 
secondary antibody diluted 1:1000 was applied for 1 hour at 37 °C in the dark. 
Subsequently the glass slides were washed with antibody solution, PCS and ddH2O. 
To stain the nucleus Hoechst 33258 at a final concentration of 0.5 µg/ml was added 
for 5 minutes and removed with ddH2O. Mowiol 4-88 was used to fix the coverslips 
on microscope slides and embed the cells. Images of the stained cells were taken 
using an epifluorescence microscopy on an Olympus IX50.   
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9 Appendix 
9.1.1 Abbreviations 
Abbreviation  
ADP adenosine diphosphate 
ADPr ADP-ribose 
AIF apoptosis inducing factor 
ANT adenine nucleotide translocase 
APAF-1 apoptotic protease activating factor 1 
ARH ADP-ribosylhydrolase 
ART ADP-ribosyltransferase 
ARTC ADP-ribosyltransferase cholera toxin like 
ARTD ADP-ribosyltransferase diphtheria toxin like 
ASC apoptosis-associated speck-like protein containing a CARD 
ATP adenosine triphosphate 
BAK BCL-2 antagonist killer 
BAX BCL-2-associated protein X 
BCRT BRCA1 C-terminus 
BER base excision repair 
BH B-cell homology 
BIR baculoviral IAP repeat 
CAD caspase-activated DNase 
CARD caspase recruitment domain 
CDK cycline dependent kinase 
cFLIP cellular FLICE-like inhibitory protein 
CLR C-type lectin receptors 
CMV cytomegalovirus 
cyt c cytochrome c 
DAMP damage-associated molecular pattern 
DD death domain 
DED death effector domain 
DISC death inducing signaling complex 
DNA desoxy-ribonucleic acid 
dsDNA double stranded DNA 
E-rich glutamate rich region 
ER endoplasmatic reticulum 
FACS fluorescence-activated cell sorting 
G-rich glycine rich region 
GFP green fluorescent protein 
GST glutathione S-transferase 
HA hemagglutinin 
HFT HeLa Flp-In T-Rex 
HPLC high-pressure liquid chromatography 
IAP inhibitor of apoptosis 
IBM IAP binding motif 
ICAD inhibitor of CAD 
IF immunofluorescence 
IMS intermembrane space 
kb kilo bases 
kD kilo Dalton 
LMB Leptomycin B 
LRR leucine rich repeat 
LRR leucine-rich repeat 
LT lethal toxin 
mADPr mono-ADPr 
mART mono-ADP-ribosyltransferase 
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MDP muramyl dipeptide 
MEF murine embryo fibroblasts 
MMP mitochondrial membrane permeabilization 
NAD nicotinamide adenine dinucleotide 
NBD nucleotide binding domain 
NES nuclear export sequence 
NF-κB nuclear factor κ-light chain enhancer of activated B cells 
NLR nucleotide-binding-and-oligomerization domain [Nod] and leucine-rich-repeat-
containing receptors 
NLS nuclear localization sequence 
NOD nucleotide binding and oligomerization domain 
PAMP pathogen-associated molecular pattern 
PAR poly-ADP-ribose 
PARG poly-ADP-ribose glycohydrolase 
PARP poly-ADP-ribose polymerase 
PARP poly-ADP-ribose polymerase 
PBM PAR binding motif 
PBZ PAR binding zinc finger 
PI propidium iodide 
PS phosphatidyl serine 
PTM post translational modification 
PYD pyrin domain 
REF rat embryo fibroblast 
RLR RIG-I-like receptors 
RNA ribonucleic acid 
ROS reactive oxygen species 
RRM RNA recognition motif 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
ssDNA single stranded DNA 
TAP tandem affinity purification 
TLR toll-like receptor 
TM transmembrane 
TNF tumor necrosis factor 
TNFR tumor necrosis factor receptor 
TpT tRNA 2’phosphotransferase 
tRNA transfer ribonucleic acid 
TUNEL terminal deoxynuclotidyl transferase-mediated dUTP nick-end labeling 
UIM ubiquitin interacting motif 
UV ultraviolet 
VDAC voltage-dependent ion channel 
ZF zinc finger 
ΔΨm mitochondrial transmembrane permeabilization 
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